STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

SUSAN G KOMEN BREAST CANCER FOUNDATION: Form 990, tax year 2017

View the entire original 990 at ProPublica ↗

Organization
SUSAN G KOMEN BREAST CANCER FOUNDATION (EIN 75-1835298)
Tax period
2017-04-01 to 2018-03-31
Filed
2018-12-14
IRS object ID
201843489349301169
Schema version
2017v2.3
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2018-12-14T17:35:07-06:00ReturnTs
Tax Period End2018-03-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1ERNST & YOUNG US LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line11901 6TH AVE NAddressLine1Txt
CityBIRMINGHAMCityNm
State AbbreviationALStateAbbreviationCd
ZIP35203ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2017-04-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN751835298EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1SUSAN G KOMEN BREAST CANCER FDN INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% RIA WILLIAMSInCareOfNm
Business Name ControlSUSABusinessNameControlTxt
Phone9728551600PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line15005 LBJ Freeway suite 526AddressLine1Txt
CityDallasCityNm
State AbbreviationTXStateAbbreviationCd
ZIP752446125ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonPAULA SUE SCHNEIDERPersonNm
Person TitlePRESIDENT AND CEOPersonTitleTxt
Phone9728551600PhoneNum
Signature2018-12-14SignatureDt

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonKATHY PITTSPreparerPersonNm
PTINP00292940PTIN
Phone2052260027PhoneNum

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address97.77.198.2IPv4AddressTxt
FieldValueIRS element (for citing)
Federal Original Submission Id75306120183485000015FederalOriginalSubmissionId
Federal Original Submission Id2018-12-14FederalOriginalSubmissionIdDt
Filing License TypePFilingLicenseTypeCd
At Submission Creation Device IdEFEC630553F7A05BD707F6467E755DCD1324F206AtSubmissionCreationDeviceId
At Submission Filing Device Id69C071E2F2C5E195884386C1B3C530989D25512EAtSubmissionFilingDeviceId
FieldValueIRS element (for citing)
Tax2017TaxYr
Build TS2019-02-21 02:37:17ZBuildTS

Form 990 IRS990

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1Susan G KomenBusinessNameLine1Txt
FieldValueIRS element (for citing)
Principal OfficerPaula Sue SchneiderPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line15005 LBJ Freeway Suite 526AddressLine1Txt
CityDallasCityNm
State AbbreviationTXStateAbbreviationCd
ZIP752446125ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$109,982,784GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Group Exemption7164GroupExemptionNum
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.komen.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1982FormationYr
Legal Domicile StateTXLegalDomicileStateCd
Activity Or MissionOUR MISSION IS TO SAVE LIVES BY MEETING THE MOST CRITICAL NEEDS IN OUR COMMUNITIES AND INVESTING IN BREAKTHROUGH RESEARCH TO PREVENT AND CURE BREAST CANCER.ActivityOrMissionDesc
Voting Members Governing Body14VotingMembersGoverningBodyCnt
Voting Members Independent14VotingMembersIndependentCnt
Total Employee245TotalEmployeeCnt
Total Volunteers2640TotalVolunteersCnt
Total Gross UBI$6,100TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm-$14,562NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$55,634,984PYContributionsGrantsAmt
CY Contributions Grants$51,441,732CYContributionsGrantsAmt
PY Program Service Revenue$15,856,597PYProgramServiceRevenueAmt
CY Program Service Revenue$14,437,717CYProgramServiceRevenueAmt
PY Investment Income$3,758,190PYInvestmentIncomeAmt
CY Investment Income$14,239,081CYInvestmentIncomeAmt
PY Other Revenue-$4,906,867PYOtherRevenueAmt
CY Other Revenue-$3,380,561CYOtherRevenueAmt
PY Total Revenue$70,342,904PYTotalRevenueAmt
CY Total Revenue$76,737,969CYTotalRevenueAmt
PY Grants And Similar Paid$35,357,025PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$28,995,790CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$24,717,739PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$21,442,628CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$2,584,720PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$1,118,493CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$11,817,989CYTotalFundraisingExpenseAmt
PY Other Expenses$36,543,700PYOtherExpensesAmt
CY Other Expenses$31,719,529CYOtherExpensesAmt
PY Total Expenses$99,203,184PYTotalExpensesAmt
CY Total Expenses$83,276,440CYTotalExpensesAmt
PY Revenues Less Expenses-$28,860,280PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$6,538,471CYRevenuesLessExpensesAmt
Total Assets BOY$220,522,141TotalAssetsBOYAmt
Total Assets EOY$201,811,514TotalAssetsEOYAmt
Total Liabilities BOY$92,137,738TotalLiabilitiesBOYAmt
Total Liabilities EOY$77,405,059TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$128,384,403NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$124,406,455NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionSUSAN G. KOMEN's MISSION IS TO SAVE LIVES BY MEETING THE MOST CRITICAL NEEDS IN OUR COMMUNITIES AND INVESTING IN BREAKTHROUGH RESEARCH TO PREVENT AND CURE BREAST CANCER.MissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Activity32ActivityCd
Expense$34,254,506ExpenseAmt
Grant$26,025,613GrantAmt
Revenue$14,437,717RevenueAmt
DescGRANTS TO ACADEMIC INSTITUTIONS AND OTHER NONPROFIT ORGANIZATIONS TO SUPPORT BREAST CANCER RESEARCH PROJECTS INCLUDING THOSE FOCUSED ON THE BIOLOGY OF BREAST CANCER; EARLY DETECTION, DIAGNOSIS, AND PREVENTION STRATEGIES; DEVELOPING TARGETED THERAPIES, OVERCOMING BREAST CANCER PROGRESSION, TREATMENT RESISTANCE AND METASTASIS, PREDICTING RISK, DEVELOPING NEW IMAGING TECHNIQUES, AND UNDERSTANDING AND ADDRESSING DISPARITIES IN OUTCOMES AS WELL AS RESEARCH RESOURCES AND CONFERENCES. SEE SCHEDULE O FOR ADDITIONAL DETAILS.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Activity32ActivityCd
Expense$23,555,222ExpenseAmt
Grant$555,547GrantAmt
Revenue$0RevenueAmt
DescPROVISION OF BREAST HEALTH/CANCER EDUCATION MATERIALS AND PATIENT SUPPORT PROGRAMS, SUCH AS THE KOMEN BREAST CARE HELPLINE, CLINICAL TRIAL INFORMATION HELPLINE, AND TREATMENT ASSISTANCE PROGRAM, WERE MADE POSSIBLE DIRECTLY BY KOMEN AND THROUGH GRANTS TO OTHER NONPROFIT ORGANIZATIONS TO INCREASE THE PUBLIC'S KNOWLEDGE OF BREAST CANCER, ITS RISK FACTORS, THE IMPORTANCE OF EARLY DETECTION, METASTATIC BREAST CANCER, TREATMENT, SOCIAL SUPPORT, AND INFORMATION ABOUT COMMUNITY RESOURCES. SEE SCHEDULE O FOR ADDITIONAL DETAILS.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Activity32ActivityCd
Expense$5,917,427ExpenseAmt
Grant$2,414,630GrantAmt
Revenue$1,387,402RevenueAmt
DescGRANTS TO OTHER NONPROFIT ORGANIZATIONS TO SUPPORT BREAST CANCER SCREENING, DIAGNOSIS, AND TREATMENT PROGRAMS WITH A SPECIAL EMPHASIS ON PATIENT NAVIGATION, ESPECIALLY IN COMMUNITIES WHERE DISPARITIES IN OUTCOMES ARE SIGNIFICANT AND/OR ACCESS IS LIMITED. SEE SCHEDULE O FOR ADDITIONAL DETAILS.Desc
FieldValueIRS element (for citing)
Total Program Service Expenses$63,727,155TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Temp Or Permanent EndowmentsYes (true)TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecYes (true)ReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesfalseReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtfalseIndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (true)ConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgYes (true)MoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingYes (true)ProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With Officer EntfalseBusinessRlnWithOfficerEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityfalseRelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document71IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee245EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (true)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (true)Form990TFiledInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members14GoverningBodyVotingMembersCnt
Independent Voting Member14IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersYes (true)LocalChaptersInd
Policies Reference ChaptersYes (true)PoliciesReferenceChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAZStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldDCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldINStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonRIA WILLIAMSPersonNm
Phone9728551600PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line15005 LBJ Freeway Suite 526AddressLine1Txt
CityDallasCityNm
State AbbreviationTXStateAbbreviationCd
ZIP75244ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (32 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeIndFormer Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
Connie O'Neill
Chair of the Board1.00.0Yes (X)Yes (X)$0$0$0
Linda Custard
BOARD MEMBER1.00.0Yes (X)$0$0$0
Jane Abraham
BOARD MEMBER1.00.0Yes (X)$0$0$0
Alan Feld
BOARD MEMBER1.00.0Yes (X)$0$0$0
Dr Olufunmilayo Olopade
BOARD MEMBER1.00.0Yes (X)$0$0$0
Janet Dunn Frantz
BOARD MEMBER1.00.0Yes (X)$0$0$0
Dan Glennon
BOARD MEMBER and Treasurer1.00.0Yes (X)Yes (X)$0$0$0
Melissa Maxfield
BOARD MEMBER1.00.0Yes (X)$0$0$0
Meghan Shannon
BOARD MEMBER1.00.0Yes (X)$0$0$0
Trish Wheaton
BOARD MEMBER1.00.0Yes (X)$0$0$0
Angela Zepeda
BOARD MEMBER1.00.0Yes (X)$0$0$0
Kim Bohr
BOARD MEMBER (Beg. 6/17)1.00.0Yes (X)$0$0$0
Peter D Brundage
BOARD MEMBER (Beg. 6/17)1.00.0Yes (X)$0$0$0
Andrew Robinson
BOARD MEMBER (Beg. 6/17)1.00.0Yes (X)$0$0$0
Linda Wilkins
BOARD MEMBER (End 6/17)1.00.0Yes (X)$0$0$0
Kaye Ceille
BOARD MEMBER (End 6/17)1.00.0Yes (X)$0$0$0
Paula Schneider
President and CEO (Beg. 10/17)55.00.0Yes (X)$137,155$0$6,155
Robert Green
Chief Financial Officer55.00.0Yes (X)$284,384$0$10,809
Adam Vanek BEG 417
Gen. Counsel & Asst Corp Secy55.00.0Yes (X)$166,163$0$23,926
Ellen Willmott
INTERIM CEO (END 10/17)55.00.0Yes (X)$380,456$0$26,839
Lesley Lurie END 417
Deputy Counsel & Assist Secy55.00.0Yes (X)$95,097$0$16,737
Christina Alford
SVP, Development55.00.0$282,288$0$19,315Yes (X)
Victoria Wolodzko
VP Research and Com. Health Pr55.00.0$185,526$0$21,607Yes (X)
Lori Maris
SVP, Affiliate Network55.00.0$170,432$0$18,785Yes (X)
Eric Montgomery
VP, I.T.55.00.0$194,143$0$46,653Yes (X)
Catherine Olivieri
VP, Human Resources55.00.0$218,036$0$52,214Yes (X)
Andrea Rader
Sr Dir, Com. (End 04/18)55.00.0$172,769$0$28,449Yes (X)
Ria Williams
Controller55.00.0$172,059$0$42,500Yes (X)
Subhendu Rath
Sr Dir, IT Enterprise Systems55.00.0$164,799$0$28,697Yes (X)
Vanessa Hewitt
Sr Dir, Internal Audit55.00.0$158,438$0$30,560Yes (X)
Kimberly Sabelko
Sr Dir, Scientific Strategy55.00.0$154,755$0$30,281Yes (X)
Dr Judith Salerno
Former President & CEO0.00.0$271,623$0$0Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$3,208,123TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$403,527TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K49IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedYes (true)FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmtAddress Line1ContractorAddress/ForeignAddress/AddressLine1TxtCityContractorAddress/ForeignAddress/CityNmProvince Or StateContractorAddress/ForeignAddress/ProvinceOrStateNmCountryContractorAddress/ForeignAddress/CountryCdForeign PostalContractorAddress/ForeignAddress/ForeignPostalCd
Event 360
205 N Michigan AveCHICAGOIL60601Event Management$6,169,963
Stephen Thomas Ltd
Direct Marketing SS$1,236,588184 FRONT STREET EAST SUITE 501TORONTOONTARIOCAM5A 4N3
The Advertising Council Inc
815 Second Avenue 9th floorNEW YORKNY10017Marketing$649,147
Blackbaud Inc
PO Box 930256ATLANTAGA311930256Donation Software Ss$583,144
Laurel Strategies Inc
4A Oxford StreetCHEVY CHASEMD20815Consulting$520,000
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K19CntrctRcvdGreaterThan100KCnt
Federated Campaigns$359,104FederatedCampaignsAmt
Fundraising$16,005,958FundraisingAmt
All Other Contributions$35,076,670AllOtherContributionsAmt
Noncash Contributions$226,197NoncashContributionsAmt
Total Contributions$51,441,732TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescAffiliate Research fundsDesc
Business900099BusinessCd
Total Revenue Column$14,437,717TotalRevenueColumnAmt
Related Or Exempt Func Income$14,437,717RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$14,437,717TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$5,589,970TotalRevenueColumnAmt
Exclusion$5,589,970ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$77,303TotalRevenueColumnAmt
Exclusion$77,303ExclusionAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$36,121,988SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$27,472,877SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$8,649,111SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$8,649,111TotalRevenueColumnAmt
Exclusion$8,649,111ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$723,932FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$16,005,958ContriRptFundraisingEventAmt
Fundraising Direct Expenses$5,693,721FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$4,969,789TotalRevenueColumnAmt
Exclusion-$4,969,789ExclusionAmt
FieldValueIRS element (for citing)
Gaming Gross Income$0GamingGrossIncomeAmt
Gaming Direct Expenses$0GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$16,300GrossSalesOfInventoryAmt
Cost Of Goods Sold$78,217CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column-$61,917TotalRevenueColumnAmt
Related Or Exempt Func Income-$61,917RelatedOrExemptFuncIncomeAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmtExclusionExclusionAmt
SHARED SERVICES INTERCOMPANY900099$1,449,319$1,449,319$0$0
Other Income900099$124,523$0$6,100$118,423
FieldValueIRS element (for citing)
Other Revenue Total$1,573,842OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$76,737,969TotalRevenueColumnAmt
Related Or Exempt Func Income$15,825,119RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$6,100UnrelatedBusinessRevenueAmt
Exclusion$9,465,018ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$26,648,984TotalAmt
Program Services$26,648,984ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$2,346,806TotalAmt
Program Services$2,346,806ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$2,385,305TotalAmt
Program Services$1,518,488ProgramServicesAmt
Management And General$524,165ManagementAndGeneralAmt
Fundraising$342,652FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$15,494,732TotalAmt
Program Services$9,844,534ProgramServicesAmt
Management And General$3,409,690ManagementAndGeneralAmt
Fundraising$2,240,508FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$697,170TotalAmt
Program Services$450,252ProgramServicesAmt
Management And General$143,152ManagementAndGeneralAmt
Fundraising$103,766FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$1,790,058TotalAmt
Program Services$1,117,213ProgramServicesAmt
Management And General$415,564ManagementAndGeneralAmt
Fundraising$257,281FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$1,075,363TotalAmt
Program Services$679,564ProgramServicesAmt
Management And General$243,794ManagementAndGeneralAmt
Fundraising$152,005FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$152,020TotalAmt
Program Services$71,797ProgramServicesAmt
Management And General$24,793ManagementAndGeneralAmt
Fundraising$55,430FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$451,550TotalAmt
Program Services$265,925ProgramServicesAmt
Management And General$93,057ManagementAndGeneralAmt
Fundraising$92,568FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$210,678TotalAmt
Program Services$210,678ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$1,118,493TotalAmt
Fundraising$1,118,493FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$69,358TotalAmt
Program Services$0ProgramServicesAmt
Management And General$69,358ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$1,954,534TotalAmt
Program Services$1,277,995ProgramServicesAmt
Management And General$101,529ManagementAndGeneralAmt
Fundraising$575,010FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$9,016,836TotalAmt
Program Services$5,380,940ProgramServicesAmt
Management And General$104,276ManagementAndGeneralAmt
Fundraising$3,531,620FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$1,638,065TotalAmt
Program Services$1,249,384ProgramServicesAmt
Management And General$160,872ManagementAndGeneralAmt
Fundraising$227,809FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$965,029TotalAmt
Program Services$606,865ProgramServicesAmt
Management And General$177,043ManagementAndGeneralAmt
Fundraising$181,121FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,335,480TotalAmt
Program Services$775,872ProgramServicesAmt
Management And General$470,989ManagementAndGeneralAmt
Fundraising$88,619FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$262,622TotalAmt
Program Services$201,420ProgramServicesAmt
Management And General$61,202ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$587,266TotalAmt
Program Services$275,331ProgramServicesAmt
Management And General$246,241ManagementAndGeneralAmt
Fundraising$65,694FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$364,269TotalAmt
Program Services$214,524ProgramServicesAmt
Management And General$75,070ManagementAndGeneralAmt
Fundraising$74,675FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
Consult & Prof. Svcs$10,117,705$8,215,278$446,132$1,456,295
Equip Rental & Maint$1,535,239$863,996$285,647$385,596
Event Production$1,472,174$870,165$371,078$230,931
Bank fees$919,608$381,253$64,922$473,433

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$667,096TotalAmt
Program Services$259,891ProgramServicesAmt
Management And General$242,722ManagementAndGeneralAmt
Fundraising$164,483FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$83,276,440TotalAmt
Program Services$63,727,155ProgramServicesAmt
Management And General$7,731,296ManagementAndGeneralAmt
Fundraising$11,817,989FundraisingAmt
FieldValueIRS element (for citing)
Joint CostsYes (X)JointCostsInd

Total Joint Costs TotalJointCostsGrp

FieldValueIRS element (for citing)
Total$24,611,074TotalAmt
Program Services$10,238,777ProgramServicesAmt
Management And General$1,438,841ManagementAndGeneralAmt
Fundraising$12,933,456FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$31,823,756BOYAmt
EOY$31,040,869EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$20,419,320BOYAmt
EOY$15,710,504EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$3,718,830BOYAmt
EOY$2,934,675EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$102,613BOYAmt
EOY$209,655EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$1,176,543BOYAmt
EOY$1,215,980EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$9,239,331LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$8,071,129LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$1,639,690BOYAmt
EOY$1,168,202EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$97,151,712BOYAmt
EOY$101,757,276EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$64,468,904BOYAmt
EOY$47,753,580EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$20,773BOYAmt
EOY$20,773EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$220,522,141BOYAmt
EOY$201,811,514EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$8,991,250BOYAmt
EOY$6,873,683EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$82,800,353BOYAmt
EOY$70,283,876EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$346,135BOYAmt
EOY$247,500EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$92,137,738BOYAmt
EOY$77,405,059EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$83,312,668BOYAmt
EOY$86,358,517EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$44,746,735BOYAmt
EOY$37,722,938EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$325,000BOYAmt
EOY$325,000EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$128,384,403BOYAmt
EOY$124,406,455EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$220,522,141BOYAmt
EOY$201,811,514EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss-$6,538,471ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$228,854NetUnrlzdGainsLossesInvstAmt
Donated Services And Use Fclts-$244,500DonatedServicesAndUseFcltsAmt
Investment Expense$0InvestmentExpenseAmt
Prior Period Adjustments$0PriorPeriodAdjustmentsAmt
Other Changes In Net Assets$3,033,877OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredfalseFederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$91,606,572CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$77,337,857CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$105,234,559CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$55,634,984CurrentTaxYearMinus1YearAmt
Current Tax Year$51,441,732CurrentTaxYearAmt
Total$381,255,704TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$91,606,572CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$77,337,857CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$105,234,559CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$55,634,984CurrentTaxYearMinus1YearAmt
Current Tax Year$51,441,732CurrentTaxYearAmt
Total$381,255,704TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$37,715,158SubstantialContributorsTotAmt
Public Support Total170$343,540,546PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$4,064,746CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$3,542,123CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$2,523,145CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$2,265,964CurrentTaxYearMinus1YearAmt
Current Tax Year$5,667,273CurrentTaxYearAmt
Total$18,063,251TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$0CurrentTaxYearMinus1YearAmt
Current Tax Year$0CurrentTaxYearAmt
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$436,740CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$153,632CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$336,857CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$51,821CurrentTaxYearMinus1YearAmt
Current Tax Year$124,523CurrentTaxYearAmt
Total$1,103,573TotalAmt
FieldValueIRS element (for citing)
Total Support$400,422,528TotalSupportAmt
Gross Receipts Rltd Activities$103,084,467GrossReceiptsRltdActivitiesAmt
Public Support CY1700.85794PublicSupportCY170Pct
Public Support PY1700.86153PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Organization Belongs Afflt GrpYes (X)OrganizationBelongsAffltGrpInd

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$10,245FilingOrganizationsTotalAmt
Affiliated Group Total$19,478AffiliatedGroupTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$200,433FilingOrganizationsTotalAmt
Affiliated Group Total$234,047AffiliatedGroupTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$210,678FilingOrganizationsTotalAmt
Affiliated Group Total$253,525AffiliatedGroupTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$75,334,466FilingOrganizationsTotalAmt
Affiliated Group Total$153,056,366AffiliatedGroupTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$75,545,144FilingOrganizationsTotalAmt
Affiliated Group Total$153,309,891AffiliatedGroupTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$1,000,000FilingOrganizationsTotalAmt
Affiliated Group Total$1,000,000AffiliatedGroupTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$250,000FilingOrganizationsTotalAmt
Affiliated Group Total$250,000AffiliatedGroupTotalAmt
FieldValueIRS element (for citing)
Tot Lbbyng Grassroot Mns Non TxTotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non TxTotLbbyExpendMnsLbbyngNonTxGrp

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$1,000,000CurrentYearMinus3Amt
Current Year Minus2$1,000,000CurrentYearMinus2Amt
Current Year Minus1$1,000,000CurrentYearMinus1Amt
Current Year$1,000,000CurrentYearAmt
Total$4,000,000TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$6,000,000LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$91,934CurrentYearMinus3Amt
Current Year Minus2$218,796CurrentYearMinus2Amt
Current Year Minus1$274,215CurrentYearMinus1Amt
Current Year$253,525CurrentYearAmt
Total$838,470TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$250,000CurrentYearMinus3Amt
Current Year Minus2$250,000CurrentYearMinus2Amt
Current Year Minus1$250,000CurrentYearMinus1Amt
Current Year$250,000CurrentYearAmt
Total$1,000,000TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$1,500,000GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$52,478CurrentYearMinus3Amt
Current Year Minus2$66,033CurrentYearMinus2Amt
Current Year Minus1$19,341CurrentYearMinus1Amt
Current Year$19,478CurrentYearAmt
Total$157,330TotalAmt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceLobbying ExpensesFormAndLineReferenceDesc
ExplanationSCHEDULE C, PART II-A PUBLIC POLICY INITIATIVES HAVE THE POTENTIAL TO IMPACT PEOPLE TOUCHED BY BREAST CANCER. RECOGNIZING THE POWER OF ADVOCACY TO ACCOMPLISH ITS MISSION, KOMEN SUPPORTS LIMITED LOBBYING ACTIVITIES TO ACHIEVE EVIDENCE-BASED POLICY AND LEGISLATIVE SOLUTIONS DESIGNED TO END BREAST CANCER FOREVER.ExplanationTxt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,377,855BeginningYearBalanceAmt
Contributions$0ContributionsAmt
Investment Earnings Or Losses$10,034InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$25,799OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$1,362,090EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,376,069BeginningYearBalanceAmt
Investment Earnings Or Losses$1,786InvestmentEarningsOrLossesAmt
Other Expenditures$0OtherExpendituresAmt
End Year Balance$1,377,855EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,346,721BeginningYearBalanceAmt
Investment Earnings Or Losses$29,808InvestmentEarningsOrLossesAmt
Other Expenditures$460OtherExpendituresAmt
End Year Balance$1,376,069EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,346,267BeginningYearBalanceAmt
Investment Earnings Or Losses$4,717InvestmentEarningsOrLossesAmt
Other Expenditures$4,263OtherExpendituresAmt
End Year Balance$1,346,721EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,325,000BeginningYearBalanceAmt
Contributions$0ContributionsAmt
Investment Earnings Or Losses$23,736InvestmentEarningsOrLossesAmt
Other Expenditures$2,469OtherExpendituresAmt
End Year Balance$1,346,267EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.73000BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.24000PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.03000TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgfalseEndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd

Land LandGrp

FieldValueIRS element (for citing)
Book Value$0BookValueAmt
FieldValueIRS element (for citing)
BuildingsBuildingsGrp

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$610,067OtherCostOrOtherBasisAmt
Depreciation$225,951DepreciationAmt
Book Value$384,116BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$2,283,342OtherCostOrOtherBasisAmt
Depreciation$2,099,946DepreciationAmt
Book Value$183,396BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$6,345,922OtherCostOrOtherBasisAmt
Depreciation$5,745,232DepreciationAmt
Book Value$600,690BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$1,168,202TotalBookValueLandBuildingsAmt
Financial DerivativesFinancialDerivativesGrp
Closely Held Equity InterestsCloselyHeldEquityInterestsGrp

Other Securities OtherSecuritiesGrp (2 entries)

DescDescBook ValueBookValueAmtMethod ValuationMethodValuationCd
Long/short equity fund$1,165,580F
Private equity fund$46,588,000F
FieldValueIRS element (for citing)
Total Book Value Securities$47,753,580TotalBookValueSecuritiesAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt
Total Liability$0TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
INTENDED USE OF ENDOWMENT FUNDSSCHEDULE D, PART V, LINE 4 KOMEN HAS THREE PERMANENT ENDOWMENTS: GOODMAN-BRINKER, FIRNBERG, AND A GENERAL ENDOWMENT. THE GOODMAN-BRINKER ENDOWMENT IS FOR BREAST CANCER RESEARCH FELLOWSHIPS, THE FIRNBERG ENDOWMENT IS FOR BREAST CANCER EDUCATIONAL PROGRAMS AND RESEARCH AWARDS, AND THE GENERAL ENDOWMENT'S EARNINGS ARE RESTRICTED FOR ORGANIZATIONAL MISSION ACTIVITIES.
FIN 48 (ASC740) FINANCIAL STATEMENT DISCLOSURESCHEDULE D, PART X, LINE 2 THE ORGANIZATION IS SUBJECT TO A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. THERE WERE NO UNCERTAIN TAX POSITIONS RECORDED IN THE CONSOLIDATED FINANCIAL STATEMENTS AT MARCH 31, 2018 OR MARCH 31, 2017.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (18 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
Central America and the Caribbean02GrantmakingEducation$68,416
Central America and the Caribbean01GrantmakingScreening$45,000
East Asia and the Pacific02GrantmakingResearch$269,871
Europe (Including Iceland and Greenland)09GrantmakingResearch$1,054,471
Middle East and North Africa03GrantmakingEducation$21,841
North America05GrantmakingResearch$672,834
North America02GrantmakingScreening$61,239
South America01GrantmakingEducation$53,500
South America01GrantmakingScreening$55,000
South America01GrantmakingTreatment$34,880
Sub-Saharan Africa01GrantmakingEducation$9,754
Europe (Including Iceland and Greenland)04Program ServicesProgram Support$16,677
North America07Program ServicesProgram Support$69,529
North America01Program ServicesDirect Mail Processing$9,080,694
North America02Program ServicesMarketing Support$192,216
North America01Program ServicesSoftware Maintenance$4,577
South America02Program ServicesProgram Support$43,405
Sub-Saharan Africa03Program ServicesProgram Support$23,581
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees45SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee3ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee48TotalEmployeeCnt
Subtotal Spent$11,753,904SubtotalSpentAmt
Continuation Spent$23,581ContinuationSpentAmt
Total Spent$11,777,485TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (27 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxt
North AmericaScreening Education Education Research Education Education Research Research Screening Research Research Screening Screening Research Research Research Treatment Research Education Research Research Education Research Education Research Research Research Research EDUCATION, TREATMENT RESEARCH RESEARCH, SCREENING, EDUCATION TREATMENT EDUCATION RESEARCH SCREENING, TREATMENT RESEARCH RESEARCH EDUCATION, TREATMENT RESEARCH SCREENING, TREATMENT RESEARCH RESEARCH EDUCATION, TREATMENT EDUCATION EDUCATION EDUCATION, TREATMENT RESEARCH RESEARCH RESEARCH RESEARCH RESEARCH RESEARCH EDUCATION, SCREENING, TREATMENT RESEARCH RESEARCH EDUCATION RESEARCH TREATMENT EDUCATION RESEARCH EDUCATION, RESEARCH RESEARCH RESEARCH EDUCATION RESEARCH RESEARCH RESEARCH RESEARCH RESEARCH RESEARCH RESEARCH TREATMENT RESEARCH RESEARCH EDUCATION, RESEARCH EDUCATION RESEARCH EDUCATION, RESEARCH EDUCATION EDUCATION RESEARCH RESEARCH RESEARCH RESEARCH RESEARCH RESEARCH EDUCATION, RESEARCH EDUCATION EDUCATION, SCREENING R$59,241Wire Transfe
Central America and the CaribbeanScreening$28,416Wire Transfe
Middle East and North AfricaResearch$10,000Wire Transfe
North AmericaTreatment$50,000Wire Transfe
South AmericaEducation$53,500Wire Transfe
Sub-Saharan AfricaResearch$9,754Wire Transfe
Europe (including Iceland and Greenland)Screening$35,640Wire Transfe
Europe (including Iceland and Greenland)Education$35,000Wire Transfe
South AmericaResearch$55,000Wire Transfe
Europe (including Iceland and Greenland)Research$30,000Wire Transfe
Europe (including Iceland and Greenland)Education$120,000Wire Transfe
Central America and the CaribbeanResearch$45,000Wire Transfe
East Asia and the PacificResearch$149,871Wire Transfe
Europe (including Iceland and Greenland)Research$148,128Wire Transfe
Europe (including Iceland and Greenland)Treatment$60,000Wire Transfe
South AmericaEducation$34,880Wire Transfe
Europe (including Iceland and Greenland)Education$190,703Wire Transfe
Middle East and North AfricaEducation$6,500Wire Transfe
North AmericaResearch$190,000Wire Transfe
Europe (including Iceland and Greenland)Research$135,000Wire Transfe
Central America and the CaribbeanResearch$40,000Wire Transfe
North AmericaResearch$149,320Wire Transfe
Middle East and North AfricaResearch$5,341Wire Transfe
North AmericaResearch$55,121Wire Transfe
East Asia and the PacificResearch$120,000Wire Transfe
North AmericaResearch$228,394Wire Transfe
Europe (including Iceland and Greenland)Education, Screening Treatment$300,000Wire Transfe
FieldValueIRS element (for citing)
Total501c3 Org28Total501c3OrgCnt
Transfer To Foreign CorpfalseTransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipYes (true)ForeignCorpOwnershipInd
Passive Foreign Investmest CofalsePassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePROCEDURES FOR MONITORING USE OF GRANT FUNDS OUTSIDE OF THE UNITED STATESFormAndLineReferenceDesc
ExplanationSCHEDULE F, PART I, LINE 2 AS OUTLINED IN EACH GRANT AGREEMENT, ALL GRANTEES ARE REQUIRED TO SUBMIT, AT A MINIMUM, ONE FINANCIAL AND PROGRESS REPORT WITHIN EACH YEAR OF THE GRANT TERM, AND ANY CHANGE REQUESTS THEY MAY HAVE FOR THEIR PROJECTS. ALL PROGRESS REPORTS AND REQUESTS ARE REVIEWED BY QUALIFIED STAFF. SEE SCHEDULE I, PART IV FOR MORE DETAILS.ExplanationTxt

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Mail SolicitationsYes (X)MailSolicitationsInd
Email SolicitationsYes (X)EmailSolicitationsInd
Phone SolicitationsYes (X)PhoneSolicitationsInd
In Person SolicitationsYes (X)InPersonSolicitationsInd
Solicitation Of Non Govt GrantsYes (X)SolicitationOfNonGovtGrantsInd
Special Fundraising EventsYes (X)SpecialFundraisingEventsInd
Agrmt Prof Fundraising ActyYes (true)AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp (6 entries)

ActivityActivityTxtFundraiser Control Of FundsFundraiserControlOfFundsIndGross ReceiptsGrossReceiptsAmtRetained By ContractorRetainedByContractorAmtNet To OrganizationNetToOrganizationAmtAddress Line1ForeignAddress/AddressLine1TxtCityForeignAddress/CityNmProvince Or StateForeignAddress/ProvinceOrStateNmCountryForeignAddress/CountryCdForeign PostalForeignAddress/ForeignPostalCdAddress Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCd
Event 360
Fundraising Consultingfalse$15,672,171$380,000$15,292,171
Stephen Thomas LTD
Direct Marketingfalse$14,447,032$464,592$13,982,441184 Front Street East Suite 501TorontoOntarioCAM5A 4N3
Infinite Agency
Marketing Consultingfalse$1,326,000$126,522$1,199,478PO Box 51706LafayetteLA70505
Artsmarketing Svcs Inc
Telemarketgfalse$111,220$63,412$47,808260 King Street East Suite 500TorontoOntarioCAM5A4L5
Merkle Inc
Direct Marketingfalse$49,105100 Jamison CourtHagerstownMD21740
Bob Carter Companies
Fundraising Consultingfalse$34,862400 Madison Drive Suite 204SarasotaFL34236
FieldValueIRS element (for citing)
Total Gross Receipts$31,556,423TotalGrossReceiptsAmt
Total Retained By Contractors$1,118,493TotalRetainedByContractorsAmt
Total Net To Organization$30,521,898TotalNetToOrganizationAmt
Licensed StatesALLicensedStatesCd
Licensed StatesAKLicensedStatesCd
Licensed StatesAZLicensedStatesCd
Licensed StatesARLicensedStatesCd
Licensed StatesCALicensedStatesCd
Licensed StatesCOLicensedStatesCd
Licensed StatesCTLicensedStatesCd
Licensed StatesDCLicensedStatesCd
Licensed StatesFLLicensedStatesCd
Licensed StatesGALicensedStatesCd
Licensed StatesHILicensedStatesCd
Licensed StatesIDLicensedStatesCd
Licensed StatesILLicensedStatesCd
Licensed StatesINLicensedStatesCd
Licensed StatesIALicensedStatesCd
Licensed StatesKSLicensedStatesCd
Licensed StatesKYLicensedStatesCd
Licensed StatesLALicensedStatesCd
Licensed StatesMELicensedStatesCd
Licensed StatesMDLicensedStatesCd
Licensed StatesMALicensedStatesCd
Licensed StatesMILicensedStatesCd
Licensed StatesMNLicensedStatesCd
Licensed StatesMSLicensedStatesCd
Licensed StatesMOLicensedStatesCd
Licensed StatesMTLicensedStatesCd
Licensed StatesNELicensedStatesCd
Licensed StatesNVLicensedStatesCd
Licensed StatesNHLicensedStatesCd
Licensed StatesNJLicensedStatesCd
Licensed StatesNMLicensedStatesCd
Licensed StatesNYLicensedStatesCd
Licensed StatesNCLicensedStatesCd
Licensed StatesNDLicensedStatesCd
Licensed StatesOHLicensedStatesCd
Licensed StatesOKLicensedStatesCd
Licensed StatesORLicensedStatesCd
Licensed StatesPALicensedStatesCd
Licensed StatesRILicensedStatesCd
Licensed StatesSCLicensedStatesCd
Licensed StatesSDLicensedStatesCd
Licensed StatesTNLicensedStatesCd
Licensed StatesTXLicensedStatesCd
Licensed StatesUTLicensedStatesCd
Licensed StatesVTLicensedStatesCd
Licensed StatesVALicensedStatesCd
Licensed StatesWALicensedStatesCd
Licensed StatesWVLicensedStatesCd
Licensed StatesWILicensedStatesCd
Licensed StatesWYLicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event13 DayEvent1Nm
Gross Receipts Event1$14,764,958GrossReceiptsEvent1Amt
Charitable Contri Event1$14,403,799CharitableContriEvent1Amt
Gross Revenue Event1$361,159GrossRevenueEvent1Amt
Cash Prizes Event1$0CashPrizesEvent1Amt
Non Cash Prizes Event1$31,735NonCashPrizesEvent1Amt
Rent Facility Costs Event1$950,464RentFacilityCostsEvent1Amt
Food And Beverage Event1$720,176FoodAndBeverageEvent1Amt
Other Direct Expenses Event1$3,503,257OtherDirectExpensesEvent1Amt
Event2DC RaceEvent2Nm
Gross Receipts Event2$724,107GrossReceiptsEvent2Amt
Charitable Contri Event2$533,484CharitableContriEvent2Amt
Gross Revenue Event2$190,623GrossRevenueEvent2Amt
Cash Prizes Event2$0CashPrizesEvent2Amt
Rent Facility Costs Event2$57,402RentFacilityCostsEvent2Amt
Food And Beverage Event2$34,256FoodAndBeverageEvent2Amt
Other Direct Expenses Event2$125,503OtherDirectExpensesEvent2Amt
Other Events Total3OtherEventsTotalCnt
Gross Receipts Other Events$1,240,825GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$1,068,675CharitableContriOtherEventsAmt
Gross Revenue Other Events$172,150GrossRevenueOtherEventsAmt
Cash Prizes Other Events$0CashPrizesOtherEventsAmt
Non Cash Prizes Other Events$1,787NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events$86,612RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events$112,000FoodAndBeverageOtherEventsAmt
Entertainment Other Events$47,090EntertainmentOtherEventsAmt
Oth Direct Expnss Other Events$23,439OthDirectExpnssOtherEventsAmt
Gross Receipts Total$16,729,890GrossReceiptsTotalAmt
Charitable Contributions Tot$16,005,958CharitableContributionsTotAmt
Gross Revenue Total Events$723,932GrossRevenueTotalEventsAmt
Cash Prizes Total Events$0CashPrizesTotalEventsAmt
Non Cash Prizes Total Events$33,522NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events$1,094,478RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$866,432FoodAndBeverageTotalEventsAmt
Entertainment Total Events$47,090EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$3,652,199OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$5,693,721DirectExpenseSummaryEventsAmt
Net Income Summary-$4,969,789NetIncomeSummaryAmt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceNET INCOME SUMMARYFormAndLineReferenceDesc
ExplanationSCHEDULE G PART II Gross receipts are reduced by the amount of contributions, per IRS instructions. The contributions for fiscal year 2018 were $16,005,958.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (142 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
African Women's Cancer Awareness Assoc
8955 Edmonston RoadGreenbeltMD20770731704355501(C)(3)$57,004Research
Albany Medical College
Attn Frances AlbertAlbanyNY12208141338310501(C)(3)$150,000Education
American Association for Cancer Research
615 Chestnut Street 17th FlPhiladelphiaPA191064404236251649501(C)(3)$328,000Research
American Association on Health & Disabil
110 N Washington StreetSuite 328JRockvilleMD20850521884887501(C)(3)$44,165Education
American Jewish Joint
Attn Itai ShamirNew YorkNY100174014131656634501(C)(3)$112,500Research
American Society of Clinical Oncology
Conquer Cancer FoundationAlexandriaVA22314136180880501(C)(3)$100,000Research
Arlington Free Clinic
2921 11th Street SouthArlingtonVA22204541671883501(C)(3)$59,959Research
Baylor College Medicine
Grants - Accounts ReceivableHoustonTX770303411741613878501(C)(3)$951,217Education
Beth Israel Deaconess Medical Center
Research Finance Office BR109BostonMA02215042103881501(C)(3)$162,000Research
Boat People SOS
6066 Leesburg Pike 100Falls ChurchVA220412220541563619501(C)(3)$65,327Treatment
Boston University
580 Harrison Avenue 3-WBostonMA02118042103547501(C)(3)$108,000Research
Breast Care for Washington
4 Atlantic St SWWashingtonDC20032455574713501(C)(3)$60,000Research
Brigham & Women's Hospital
PO Box 3149BostonMA022413149042312909501(C)(3)$323,929Research
Broad Institute Inc
415 Main StreetCambridgeMA02142263428781501(C)(3)$122,996Research
Cancer Care
275 Seventh AvenueNew YorkNY10001131825919501(C)(3)$1,439,879Education
Cancer Resource Centers of Mendocino Cty
45040 Calpella StreetMendocinoCA95460680357416501(C)(3)$13,108Research
Capital Breast Care Center
3970 Reservoir Road NWWashingtonDC200571468530196603501(C)(3)$50,000Research
CASA of Maryland Inc
Attn Jennifer FreedmanHyattsvilleMD20783521372972501(C)(3)$35,000Research
Case Western Reserve University
Controllers OfficeClevelandOH441067006341018992501(C)(3)$294,311Education
Children's Hospital Boston
Research FinanceBostonMA022414413042774441501(C)(3)$108,000Research
Cold Spring Harbor Laboratory
Attn Walter GoldschmidtsCold Spring HarborNY11724112013303501(C)(3)$168,000Education, Research
Columbia University Medical Center
722 West 168th Street 4th FloorNew YorkNY10032135598093501(C)(3)$646,000Education
Cornell University
Attn Ilene LambiaseIthacaNY14850150532082501(C)(3)$48,000Screening
Dana Farber Cancer Institute
44 Binney Street Mail Stop 439CBostonMA02115042263040501(C)(3)$1,994,658Education, Screening, Treatment
Doctors Community Hospital
8118 Good Luck RoadLanhamMD207063502521638026501(C)(3)$75,000Research
Dr Susan Love Research Foundation
2811 Wilshire BlvdSanta MonicaCA90403770009065501(C)(3)$25,000Research
Duke University Medical Center
PO Box 602651CharlotteNC282602651560532129501(C)(3)$536,052Research
Eastern Michigan University
Attn Susan ShipleyYpsilantiMI48197382953297501(C)(3)$225,074Research
Emory University Winship Cancer Inst
PO Box 935084AtlantaGA311935084580566256501(C)(3)$150,000Research
Ethiopian Community Development Council
Attn Azeb TadesseArlingtonVA22204521308986501(C)(3)$50,000Education
Facing Our Risk of Cancer Empowered
16057 Tampa Palms Blvd W 373TampaFL33647650927702501(C)(3)$6,000Education, Research
Fox Chase Cancer Center
333 Cottman AvenuePhiladelphiaPA19111232003072501(C)(3)$150,000Education
Fred Hutchinson Cancer Research Center
PO Box 19024 Mailstop J6-330SeattleWA981091024563744111501(C)(3)$334,998Education, Screening
George Mason University
4400 University Drive MSN 4C6FairfaxVA22030540836354501(C)(3)$29,686Research
George Washington University
Grants and Contracts Accounting SvcAshburnVA20147530196584501(C)(3)$44,653Education, Screening, Treatment
Georgetown U
Attn Jemas ReisertWashingtonDC200571164530196603501(C)(3)$243,000Research
Georgia Tech Research Corporation
505 Tenth Street NWAtlantaGA30318580603146501(C)(3)$150,000Research
Global Biological Standards Institute
1020 19th Street NW Suite 550WashingtonDC20036611705421501(C)(3)$8,000Research
H Lee Moffitt Cancer Center
12902 Magnolia DriveTampaFL33612593238636501(C)(3)$348,000Education
Harvard Medical School
Holyoke Center Room 600CambridgeMA02138042103580501(C)(3)$97,000Research
Harvard University
25 Shattuck Street Sponsored PrgmsBostonMA02115042103580501(C)(3)$120,000Research
Henry Ford Health System
One Ford Place 5EDetroitMI48202381357020501(C)(3)$200,000Research
Howard University
2041 Georgia Avenue NWWashingtonDC20060530204707501(C)(3)$49,994Education
Hudson-Alpha Institute for Biotechnology
601 Genome WayHuntsvilleAL35801432059317501(C)(3)$28,125Education
Indiana University (Indianapolis)
PO Box 66057IndianapolisIN46266356001673501(C)(3)$1,477,684Treatment
Johns Hopkins University
1101 East 33rd Street Eastern C220BaltimoreMD21218520595110501(C)(3)$2,391,260Research
Korean Community Svc Ctr of Greater WA
Attn Jai Hoon JungAnnandaleVA22003386005984501(C)(3)$10,000Education
Leland Stanford Jr University
PO Box 44253San FranciscoCA941444253941156365501(C)(3)$546,989Screening, Treatment
Living Beyond Breast Cancer
Attn Jean Sachs CEOHaverfordPA19041530196932501(C)(3)$20,000Education, Screening
Maasai Wildernes Conservation Fund
PO Box 1413Santa BarbaraCA93102541943145501(C)(3)$60,000Research
Mary's Ctr for Maternal&Child Care Inc
2333 Ontario Road NWWashingtonDC20009521594116501(C)(3)$125,291Education
Massachusetts General Hospital
PO Box 414876BostonMA022414876042697983501(C)(3)$528,910Education
Mayo Clinic Jacksonville
Griffin Building Room 170JacksonvilleFL32224593337028501(C)(3)$100,000Research
Mayo Clinic Rochester
dba Mayo Clinic College of MedicineRochesterMN559034008416011702501(C)(3)$200,000Education
Medical College of Wisconsin
1234 Any StreetAnywhereTX75244390806261501(C)(3)$150,000Research
Medical Univeristy of South Carolina
171 Ashley AvenueCharlestonSC29425576000722501(C)(3)$120,000Research
Memorial Sloan-Kettering Cancer Ctr
633 3rd Avenue 28th FloorNew YorkNY10017131924236501(C)(3)$160,000Research
Metropolitan Chicago Breast Cancer
1645 W Jackson Blvd Ste 450ChicagoIL606123244262264895501(C)(3)$100,000Education, Screening, Treatment
MidMichigan Medical Center-Gratiot
300 East Warwick DriveAlmaMI48801381437919501(C)(3)$13,889Research
Mobile Medical Care Inc
9309 Old Georgetown RoadBethesdaMD208141620237022588501(C)(3)$29,416Screening
Mount Sinai School of Medicine
Sponsored Proj ActgNew YorkNY100296574136171197501(C)(3)$396,000Education
Neighborhood Health
6677 Richmond HighwayAlexandriaVA22306541849891501(C)(3)$139,917Research
New York University School of Med
General Accounting/Accounts ReceivaNew YorkNY10016135562308501(C)(3)$120,000Education
North Carolina Central University
1801 Fayetteville StreetDurhamNC27707566000730501(C)(3)$135,000Research
Northwestern University - Chicago
633 ClarkEvanstonIL60208362167817501(C)(3)$448,219Treatment
Nueva Vida Inc
2000 P Street NW Suite 300WashingtonDC20036541943145501(C)(3)$64,879Research
Obesity Society
8757 Georgia AvenueSilver SpringMD20910541438429501(C)(3)$8,000Research
Oregon Health & Science University
Sponsored Program AdminPortlandOR97239752668014501(C)(3)$909,855Research
Partners for Cancer Care and Prevention
10 East Lee Street Unit 1901BaltimoreMD21202451605551501(C)(3)$67,500Research
Patient Advocate Foundation
421 Butler Farm RoadHamptonVA23666830292601501(C)(3)$25,000Research
Prevent Cancer Foundation
1600 Duke StreetAlexandriaVA22209521429544501(C)(3)$10,000Research
Primary Care Coalition-MontgomeryCty Inc
8757 Georgia Avenue 10th FloorSilver SpringMD20910521847976501(C)(3)$250,000Research
Prince William Hospital
8700 Sudley RoadManassasVA20110541307595501(C)(3)$93,057Research
Princeton University
701 Carnegie CenterPrincetonNJ08540210634501501(C)(3)$208,000Research
Program for Appropriate
PO Box 900922SeattleWA98109911157127501(C)(3)$45,646Research
Providence Portland Medical Center
4805 NE Glisan St 5F40PortlandOR97213930386906501(C)(3)$120,000Research
Purdue University
Sponsored Program ServicesChicagoIL606731235356002041501(C)(3)$150,000Research
Quantum Leap HealthCare Collaborative
3450 California StreetSan FranciscoCA941181837204284925501(C)(3)$10,000Research
Reagan Udall Foundation
Attn Georges Benjamin MDWashingtonDC20001263727917501(C)(3)$10,000Research
Research Advocacy Network
6505 West Park BoulevardPlanoTX75093566001393501(C)(3)$72,295Research
Rockefeller University
Attn Shawn Davis Ofc of DevelopmeNew YorkNY10065131624158501(C)(3)$150,000Research
Roswell Park Alliance Foundation
Department of ImmunologyBuffaloNY14263161391608501(C)(3)$158,690Research
Smith Farm Center for Healing & the Arts
1632 U Street NWWashingtonDC20009590624458501(C)(3)$50,000Research
St Joseph Medical Center
2500 Bernville RoadReadingPA196030316530196617501(C)(3)$17,257Research
Stanford University
PO Box 44253San FranciscoCA941444253941156365501(C)(3)$180,000Research
Stevens Institute of Technology
1 Castle Point TerraceHobokenNJ07030221487354501(C)(3)$60,000Research
SUNY at Stony Brook
Attn Joann DeLucia-ConlonStony BrookNY11794146013200501(C)(3)$374,389Education, Research
Supporting Our Sisters International In
2604 Pinebrook Ave C2HyattsvilleMD20785472511778501(C)(3)$10,000Research
Temple University
Attn Jeanette West PastelakPhiladelphiaPA19122231365971501(C)(3)$60,000Research
The Ohio State University College
Attn Kathy MilemColumbusOH43205316025986501(C)(3)$258,000Research
The Salk Institute
Attn Christine MarckeseLa JollaCA920371002952160097501(C)(3)$228,070Education, Research
The University of Chicago
Research AdministrationChicagoIL60637362177139501(C)(3)$334,999Research
The Vanderbilt University
PMB 406310NashvilleTN372406310620476822501(C)(3)$48,000Research
The Wistar Institute
3601 Spruce StreetPhiladelphiaPA191044265236434390501(C)(3)$150,000Research
Trustees of Columbia Univ
Sponsored Projects FinanceNew YorkNY10027135598093501(C)(3)$150,000Research
Trustees of Dartmouth College
Office of Sponsored ProjectsHanoverNH037551404020222111501(C)(3)$120,000Research
Tufts University
800 Washington StreetBostonMA02111042103634501(C)(3)$242,712Research
Tulane University Health Sciences Center
800 E CommerceHarahanLA70023720423889501(C)(3)$120,000Research
Univ of Colorado Health Sciences Cent
Attn George JohnstonDenverCO802910238846002597501(C)(3)$150,000Research
Univ of North Carolina at Chapel Hill
104 Airport Drive Suite 2200 CBChapel HillNC275991350566001393501(C)(3)$2,157,806Research
Univ of Texas MD Anderson Cancer Center
Grants ContractsHoustonTX772104390746001118501(C)(3)$774,111Research
University Miami School of Medicine
Attn Maria A GarciaAtlantaGA303845803590624458501(C)(3)$120,000Research
University of Alabama at Birmingham
1530 3rd Avenue SouthBirminghamAL352940111636005396501(C)(3)$408,000Education, Screening, Treatment
University of California-San Francisco
1600 Divisadero St Box 1710San FranciscoCA94115946036493501(C)(3)$764,159Research
University of California-Berkeley
2195 Hearst Avenue Room 130BerkeleyCA947201103946002123501(C)(3)$243,000Research
University of California-Davis
Cashiers OfficeWest SacramentoCA957989062946036494501(C)(3)$59,983Research
University of California-Los Angeles
UCLA Remittance CenterLos AngelesCA900246503956006143501(C)(3)$390,000Research
University of California-San Diego
UCSD Cashiers OfficeLa JollaCA92093956006144501(C)(3)$228,000Education, Treatment
University of Cincinnati
51 Goodman Dr Univ Hall Suite 5CincinnatiOH452210222316000989501(C)(3)$120,000Screening
University of Colorado Denver
13001 E 17th PlaceAuroraCO800452571846002597501(C)(3)$75,975Research
University of Delaware
30 Lovett AenueNewarkDE19716516000279501(C)(3)$150,000Education
University of Illinois at Chicago
809 S Marshfield Avenue MC551ChicagoIL606081264376000511501(C)(3)$104,059EDUCATION
University of Illinois-Urbana-Champaign
Grants Contracts-Post AwardSpringfieldIL627084610376000511501(C)(3)$60,000SCREENING
University of Kansas Medical Center
ATTN TIM SISKEY KANSAS CITY KS 66Kansas CityKS66160481108830501(C)(3)$583,275EDUCATION
University of Kentucky Research Fndn
Markey Cancer CenterLexingtonKY405260001616033693501(C)(3)$75,948EDUCATION
University of Massachusetts Amherst
Goodell Bldg Room 405AmherstMA010033210043167352501(C)(3)$149,944EDUCATION
University of Miami School of Medicine
Center for Cancer Prevention and GeMiamiFL33136590624458501(C)(3)$60,000RESEARCH
University of Michigan
Alexandra ThebaudAnn ArborMI481091274386006309501(C)(3)$255,000EDUCATION
University of Minnesota
McNamara Alumni CenterMinneapolisMN554552070416007513501(C)(3)$180,000RESEARCH
University of Pennsylvania
Office of Research ServicesPhiladelphiaPA191046205231352685501(C)(3)$819,727EDUCATION
University of Pittsburgh
350 Thackeray HallPittsburghPA15260250965591501(C)(3)$773,574EDUCATION
University of South CarolinaThe
1600 Hampton Street Suite 404HColumbiaSC29208576001153501(C)(3)$135,000RESEARCH
University of Southern California
Attn Robert OsunaLos AngelesCA900898001951642394501(C)(3)$818,086RESEARCH
University of Texas at Health Science Ce
Elizabeth FrantzHoustonTX77030741587488501(C)(3)$259,916EDUCATION, SCREENING
University of Utah
201 South Presidents Circle RoomSalt Lake CityUT841129020876000525501(C)(3)$296,000RESEARCH
University of Virginia at School of Medi
PO Box 400195CharlottesvilleVA229044195546001796501(C)(3)$150,000RESEARCH
University of Washington
Attn Tami SaduskySeattleWA98105916001537501(C)(3)$502,837EDUCATION
University of Wisconsin - Madison
Research Sponsored ProgramsMadisonWI537151218396006492501(C)(3)$179,383EDUCATION, SCREENING
UT HSC - San Antonio
Office of Sponsored ProgramsSan AntonioTX772293900741586031501(C)(3)$150,000RESEARCH
UT Southwestern Medical Center
UT Southwestern Grants MgmtDallasTX752841753746000203501(C)(3)$210,000RESEARCH
UTMD Anderson Cancer Ctr
1515 Holcombe Boulevard Unit 1644HoustonTX770304009746001118501(C)(3)$364,479EDUCATION, TREATMENT
Vanderbilt University Medical Center
1161 21st Avenue SouthNashvilleTN372325545620476822501(C)(3)$1,242,169EDUCATION, RESEARCH
Vermont Cancer Ctr UVM College of Med
Attn Jennifer GagnonBurlingtonVT05405030179440501(C)(3)$150,000RESEARCH
Vietnamese Resettlement Association Inc
Attn Kim O CookFalls ChurchVA22044541512549501(C)(3)$279,182RESEARCH
Virginia Commonwealth University
Attn Mark RobertsRichmondVA232843038546001758501(C)(3)$25,204RESEARCH
Washington Univ at St Louis
700 Rosedale Ave Campus Box 1034St LouisMO63112430653611501(C)(3)$1,059,427RESEARCH
Wayne State University
Sponsored Program AdminDetroitMI48201366028429501(C)(3)$143,999EDUCATION
Weill Medical College of Cornell Univ
1300 York AvenueNew YorkNY10061131623978501(C)(3)$60,000EDUCATION
Whitehead Inst for Biomedical Research
9 Cambridge CenterCambridgeMA021421479061043412501(C)(3)$48,000EDUCATION
Whitman-Walker Clinic
1701 14th Street NWWashingtonDC20009521122122501(C)(3)$194,136RESEARCH
Yale University
2 Whitney AvenueNew HavenCT06510060646973501(C)(3)$200,000RESEARCH
Young Survival Coalition
Lori AtkinsonNew YorkNY10006134057685501(C)(3)$10,000RESEARCH
FieldValueIRS element (for citing)
Total501c3 Org142Total501c3OrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePROCEDURES FOR MONITORING THE USE OF GRANTSFormAndLineReferenceDesc
ExplanationSCHEDULE I PART I LINE 2 SUSAN G. KOMEN'S (KOMEN) POLICIES FOR MANAGING GRANTS FROM THE TIME OF PRE-AWARD THROUGH CLOSEOUT ARE DESIGNED TO MAXIMIZE FLEXIBILITY WHILE MAINTAINING A HIGH STANDARD OF ACCOUNTABILITY AND PRESERVING THE INTEGRITY OF THE REVIEW AND AWARD PROCESS. KOMEN REQUIRES ALL GRANTEES TO SIGN A GRANT AGREEMENT SETTING FORTH THE TERMS OF THE GRANT, INCLUDING: PURPOSE, AMOUNT, BUDGETARY RESTRICTIONS, DURATION, PAYMENT SCHEDULE, REPORTING REQUIREMENTS, AUDIT, AND EARLY TERMINATION RIGHTS. FOR RESEARCH GRANTS, SCIENTIFIC PROGRESS AND FINANCIAL OVERSIGHT IS MONITORED THROUGHOUT THE GRANT TERM BY A PH.D.-LEVEL RESEARCH GRANT MANAGER. FOR EDUCATION, SCREENING, AND TREATMENT GRANTS, PROGRESS AND FINANCIAL OVERSIGHT IS MONITORED OR SUPERVISED THROUGHOUT THE GRANT TERM BY QUALIFIED PROFESSIONALS SERVING AS GRANTS MANAGERS. EACH YEAR OF THE GRANT TERM, GRANTEES ARE REQUIRED TO SUBMIT PROGRESS AND FINANCIAL REPORTS DETAILING PROGRESS TOWARD AIMS AND OBJECTIVES, MAJOR ACCOMPLISHMENTS, KEY DELIVERABLES AND CHALLENGES ENCOUNTERED, WITH A FULL ACCOUNTING OF GRANT FUNDS EXPENDED (ACTUAL VERSUS BUDGETED EXPENSES) AND WRITTEN JUSTIFICATION OF EXPENSES. AS APPROPRIATE, THE GRANTS MANAGER MAY CONDUCT SITE VISITS WITH GRANTEES TO GAIN A BETTER UNDERSTANDING OF THEIR WORK AND ADDRESS ANY CHALLENGES IMPACTING THE FUNDED PROGRAM. ALL GRANT FUNDS MUST BE EXPENDED IN ACCORDANCE WITH THE PROJECT'S APPROVED BUDGET AND ARE DISBURSED IN ACCORDANCE WITH THE SCHEDULE DOCUMENTED WITHIN THE GRANT AGREEMENT. REQUESTS FOR CHANGES TO THE DESIGN OF THE FUNDED PROJECT OR BUDGET ARE SUBJECT TO PRIOR APPROVAL BY KOMEN IN ACCORDANCE WITH THE TERMS OF THE GRANT AGREEMENT. AS PART OF ITS OVERSIGHT PRACTICES, THE TERMS OF THE GRANT AGREEMENT MAY PROVIDE KOMEN WITH, AMONG OTHER THINGS, THE RIGHT TO REQUEST WITH REASONABLE PRIOR NOTICE TO THE GRANTEE: (1) ADDITIONAL PROGRESS AND/OR FINANCIAL REPORTING FROM THE GRANTEE, (2) GRANTEE PARTICIPATION IN SITE VISITS, TELEPHONE CONFERENCES, PRESENTATIONS, OR OTHER SPEAKING ENGAGEMENTS, AND (3) WITH PRIOR WRITTEN NOTICE, ADJUSTMENT TO THE PROJECT REPORTING PERIOD AND ASSOCIATED DISBURSEMENT OF GRANT FUNDS AT ANY TIME DURING THE GRANT TERM.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentYes (true)SeverancePaymentInd
Supplemental Nonqual Rtr PlanfalseSupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsfalseAnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (14 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmount
Robert Green
Chief Financial Officer$279,292$5,092$8,644$0$2,165$0$295,193$0$0$0
Adam Vanek BEG 417
Gen. Counsel & Asst Corp Secy$164,539$1,624$0$0$23,926$0$190,089$0$0$0
Ellen Willmott
INTERIM CEO (END 10/17)$341,849$3,882$15,973$0$10,866$0$407,295$0$0$0$34,725
Christina Alford
SVP, Development$280,188$2,100$14,385$0$4,930$0$301,603$0$0$0
Victoria Wolodzko
VP Research and Com. Health Pr$183,156$2,370$10,914$0$10,693$0$207,133$0$0$0
Lori Maris
SVP, Affiliate Network$167,873$2,559$7,370$0$11,415$0$189,217$0$0$0
Eric Montgomery
VP, I.T.$192,148$1,995$9,526$0$37,127$0$240,796$0$0$0
Catherine Olivieri
VP, Human Resources$215,234$2,802$13,834$0$38,380$0$270,250$0$0$0
Andrea Rader
Sr Dir, Com. (End 04/18)$169,826$2,943$10,481$0$17,968$0$201,218$0$0$0
Ria Williams
Controller$170,058$2,001$8,369$0$34,131$0$214,559$0$0$0
Subhendu Rath
Sr Dir, IT Enterprise Systems$163,037$1,762$9,912$0$18,785$0$193,496$0$0$0
Vanessa Hewitt
Sr Dir, Internal Audit$156,643$1,795$9,856$0$20,704$0$188,998$0$0$0
Kimberly Sabelko
Sr Dir, Scientific Strategy$152,257$2,498$9,132$0$21,149$0$185,036$0$0$0
Dr Judith Salerno
Former President & CEO$0$271,623$0$0$0$0$271,623$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceFORM 990, SCHEDULE J, PART I, LINE 1AFormAndLineReferenceDesc
ExplanationSUPPLEMENTAL COMPENSATION INFORMATION EXCEPT AS MAY BE APPROVED IN ADVANCE FOR MEDICAL ACCOMMODATION, FIRST CLASS AND BUSINESS CLASS FARES FOR DOMESTIC TRAVEL, CANADA, THE CARIBBEAN, CENTRAL AMERICA, AND MEXICO ARE NOT REIMBURSABLE. HOWEVER, PERSONAL FREQUENT FLIER MILEAGE AND/OR COUPONS MAY BE USED FOR NO-COST UPGRADES. IN THE EVENT OF INTERNATIONAL TRAVEL WITH FLIGHT TIMES OF SIX HOURS OR MORE, AND PRE-APPROVAL BUSINESS OR FIRST CLASS TRAVEL MAY BE PERMITTED IF THERE IS A MEDICAL ACCOMODATION OR BUSINESS PURPOSE. WHENEVER POSSIBLE, DISCOUNTED FIRST CLASS AND UPGRADES ARE USED TO MINIMIZE COST. FORM 990, SCHEDULE J, PART I, LINE 4A Dr. Judith Salerno received a severance payment of $271,623.ExplanationTxt

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Works Of ArtWorksOfArtGrp
Art Historical TreasuresArtHistoricalTreasuresGrp
Art Fractional InterestArtFractionalInterestGrp
Books And PublicationsBooksAndPublicationsGrp
Clothing And Household GoodsClothingAndHouseholdGoodsGrp
Cars And Other VehiclesCarsAndOtherVehiclesGrp
Boats And PlanesBoatsAndPlanesGrp
Intellectual PropertyIntellectualPropertyGrp
Securities Publicly TradedSecuritiesPubliclyTradedGrp
Securities Closely Held StockSecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust IntrstsSecurPrtnrshpTrustIntrstsGrp
Securities MiscellaneousSecuritiesMiscellaneousGrp
Qualified Contrib Hist StructQualifiedContribHistStructGrp
Qualified Contrib OtherQualifiedContribOtherGrp
Real Estate ResidentialRealEstateResidentialGrp
Real Estate CommercialRealEstateCommercialGrp
Real Estate OtherRealEstateOtherGrp
CollectiblesCollectiblesGrp

Food Inventory FoodInventoryGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution3800ContributionCnt
Noncash Contributions Rpt F990$14,577NoncashContributionsRptF990Amt
Method Of Determining RevenuesFMVMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Drugs And Medical SuppliesDrugsAndMedicalSuppliesGrp
TaxidermyTaxidermyGrp
Historical ArtifactsHistoricalArtifactsGrp
Scientific SpecimensScientificSpecimensGrp
Archaeological ArtifactsArchaeologicalArtifactsGrp

Other Non Cash Contri Table OtherNonCashContriTableGrp (3 entries)

Non Cash CheckboxNonCashCheckboxIndDescDescContributionContributionCntNoncash Contributions Rpt F990NoncashContributionsRptF990AmtMethod Of Determining RevenuesMethodOfDeterminingRevenuesTxt
Yes (X)Tablecloths & Flowers16$3,568FMV
Yes (X)Exercise Supplies20$1,035FMV
Yes (X)Golf Equip Inventory8559$207,017FMV
FieldValueIRS element (for citing)
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (8 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
VOLUNTEERSFORM 990, PART I, LINE 6 VOLUNTEERS SERVE IN A VARIETY OF WAYS, BUT THE GREATEST NUMBERS OF VOLUNTEERS ASSIST WITH THE SUSAN G. KOMEN 3 DAY SERIES. FORM 990, PART III - PROGRAM SERVICE ACCOMPLISHMENTS SUSAN G. KOMEN IS A LEADING GLOBAL BREAST CANCER ORGANIZATION, HAVING FUNDED MORE BREAST CANCER RESEARCH THAN ANY OTHER NONPROFIT OUTSIDE THE U.S. GOVERNMENT WHILE PROVIDING REAL TIME HELP TO THOSE FACING THE DISEASE. SINCE ITS FOUNDING IN 1982, KOMEN HAS FUNDED MORE THAN $988 MILLION IN BREAST CANCER RESEARCH AND PROVIDED OVER $2.2 BILLION IN FUNDING FOR PATIENT NAVIGATION, SCREENING, DIAGNOSIS, TREATMENT, EDUCATION, HEALTH SYSTEMS IMPROVEMENT, AND PSYCHOSOCIAL SUPPORT PROGRAMS SERVING MILLIONS OF PEOPLE IN MORE THAN 60 COUNTRIES WORLDWIDE. KOMEN WAS FOUNDED BY NANCY G. BRINKER, WHO PROMISED HER SISTER, SUSAN G. KOMEN, THAT SHE WOULD END THE DISEASE THAT CLAIMED SUZY'S LIFE. RESEARCH SINCE ITS FOUNDING IN 1982, KOMEN'S RESEARCH INVESTMENTS HAVE CONTRIBUTED TO MAJOR ADVANCES IN BREAST CANCER SCIENCE. THE PROGRESS HAS BEEN SIGNIFICANT - TODAY, WE KNOW THAT BREAST CANCER IS MORE THAN A SINGLE DISEASE. WE HAVE A BETTER UNDERSTANDING OF THE GENETICS OF BREAST CANCER AND THE CRITICAL NEED TO TAILOR SCREENING, DIAGNOSIS, TREATMENT, AND PREVENTION STRATEGIES TO INDIVIDUALS THROUGH ADVANCES IN PRECISION MEDICINE. KOMEN'S RESEARCH PROGRAMS ARE FOCUSED ON BREAKTHROUGH RESEARCH TO PREVENT AND CURE BREAST CANCER THROUGH BETTER APPROACHES FOR EARLY DETECTION AND DIAGNOSIS, UNDERSTANDING METASTASIS AND RECURRENCE, AND DEVELOPING NOVEL THERAPIES FOR ALL STAGES OF BREAST CANCER, WITH THE GOAL OF SUPPORTING WORK THAT HAS SIGNIFICANT POTENTIAL TO LEAD TO NEW TREATMENTS AND TECHNOLOGIES THAT WILL REDUCE THE NUMBER OF BREAST CANCER DEATHS IN THE U.S. BY 50 PERCENT BY 2026. KOMEN'S RESEARCH PROGRAMS ARE GUIDED BY 60 OF THE WORLD'S LEADERS IN BREAST CANCER RESEARCH, ONCOLOGY AND ADVOCACY. THE SCIENTIFIC ADVISORY BOARD ASSISTS KOMEN IN SETTING ITS RESEARCH STRATEGY AND PRIORITIZING ITS RESEARCH INVESTMENT. THE KOMEN SCHOLARS LEAD AND PARTICIPATE IN KOMEN'S WORLD-CLASS SCIENTIFIC PEER REVIEW PROCESS. OUR ADVOCATES IN SCIENCE BRING THE PATIENT VOICE TO KOMEN'S RESEARCH PROGRAMS, EMPHASIZING URGENCY AND PATIENT IMPACT. KOMEN AWARDS GRANTS TO INDIVIDUAL SCIENTISTS, RESEARCH TEAMS, AND ORGANIZATIONS AROUND THE WORLD THROUGH A FAIR, TRANSPARENT, RIGOROUS, AND COMPETITIVE REVIEW PROCESS THAT ENSURES MAXIMUM IMPACT FOR OUR RESEARCH INVESTMENT. IN FY18, KOMEN AWARDED MORE THAN 60 GRANTS THROUGH ITS RESEARCH PROGRAMS TO SUPPORT SCIENTIFIC RESEARCH, COLLABORATIONS AND TRAINING IN THE UNITED STATES AND OTHER COUNTRIES, INCLUDING AUSTRALIA, CANADA, FRANCE, AND IRELAND. WE CONSIDER IT OUR RESPONSIBILITY TO ENSURE THE CONTINUITY OF BREAST CANCER RESEARCH FOR THE FUTURE. WITH FEDERAL RESEARCH BUDGETS TIGHTENING, THE PUBLIC CANNOT AFFORD TO LOSE PROMISING YOUNG INVESTIGATORS DUE TO A LACK OF FUNDING OPPORTUNITIES. TO THAT END, KOMEN AWARDED CAREER CATALYST RESEARCH GRANTS (WITH A COMPETITIVE RENEWAL OPTION) TO SUPPORT YOUNG INVESTIGATORS IN BREAST CANCER RESEARCH ADDRESSING TWO OF THE GREATEST CHALLENGES FACING BREAST CANCER PATIENTS -DRUG-RESISTANT BREAST CANCERS AND NEW APPROACHES TO COMBAT METASTATIC BREAST CANCER. KOMEN ALSO OFFERED LEADERSHIP GRANTS AND A PHASE II COMPETITIVE RENEWAL OF THE INFLAMMATORY BREAST CANCER RESEARCH INNOVATOR GRANTS. EACH MECHANISM IS FURTHER DESCRIBED BELOW: CAREER CATALYST RESEARCH GRANTS (CCR): CCR GRANTS PROVIDE UNIQUE OPPORTUNITIES FOR SCIENTISTS WHO HAVE HELD FACULTY POSITIONS FOR NO MORE THAN 5 YEARS AT THE TIME OF FULL APPLICATION TO ACHIEVE RESEARCH INDEPENDENCE. THE GOAL OF THE FY18 CCR GRANTS IS TO SUPPORT OUTSTANDING TRANSLATIONAL RESEARCH FOCUSED ON THOSE BREAST CANCERS THAT DO NOT CURRENTLY RESPOND WELL TO STANDARD THERAPIES INCLUDING TRIPLE NEGATIVE BREAST CANCER (TNBC), ER+ BREAST CANCER WITH ACQUIRED RESISTANCE, AND METASTATIC BREAST CANCER OF ALL SUB-TYPES. CCR GRANTS SUPPORT WORK THAT HAS SIGNIFICANT POTENTIAL TO LEAD TO NEW TREATMENTS AND TECHNOLOGIES THAT WILL REDUCE THE NUMBER OF BREAST CANCER DEATHS IN THE U.S. BY 50 PERCENT BY 2026. CAREER CATALYST RESEARCH GRANTS-COMPETING RENEWALS (CCR-CR): CCR-CR GRANTS WERE DESIGNED TO ADDRESS THE INTENSE COMPETITION AND LACK OF FUNDING THAT MAY CAUSE TALENTED YOUNG SCIENTISTS TO LEAVE THE FIELD. CCR-CR GRANTS ARE INTENDED TO PROVIDE CONTINUED SUPPORT TO EARLY CAREER BREAST CANCER RESEARCHERS AND CLINICIAN-SCIENTISTS WHO HAVE HAD PRIOR KOMEN CCR GRANT SUPPORT, BUT HAVE NOT YET SECURED SUPPORT AS A PRINCIPAL INVESTIGATOR THROUGH A NATIONAL INSTITUTES OF HEALTH R01 AWARD OR OTHER INDEPENDENT AWARD SIMILAR IN SCOPE. IT IS EXPECTED THAT AWARDEES WILL LEVERAGE THE CCR-CR GRANT TO SUCCESSFULLY COMPETE FOR ADDITIONAL INDEPENDENT RESEARCH FUNDING IN BREAST CANCER, AND THUS REMAIN IN THE FIELD. INFLAMMATORY BREAST CANCER (IBC) RESEARCH INNOVATOR GRANTS: GENEROUSLY SUPPORTED BY THE MILBURN FOUNDATION AND THE INFLAMMATORY BREAST CANCER RESEARCH FOUNDATION, THESE INNOVATOR GRANTS ARE INTENDED TO SPUR IDEAS THAT WILL INCREASE THE UNDERSTANDING OF HOW IBC CAN BE BETTER DIAGNOSED AND HOW BIOLOGY DRIVES ITS PROGRESSION, THEREBY LEADING TO IMPROVED PROGNOSIS AND MORE EFFECTIVE TREATMENTS FOR THOSE WITH THIS AGGRESSIVE DISEASE. THIS PROGRAM CONSISTED OF TWO STAGES. IN THE FIRST STAGE, ONE YEAR OF FUNDING WAS AWARDED TO ALLOW INVESTIGATORS TO ESTABLISH THE FOUNDATION OF A ROBUST AND INNOVATIVE IBC RESEARCH PROJECT. IN THE SECOND STAGE, AWARDEES COMPETED FOR ADDITIONAL FUNDING TO BUILD ON THEIR ORIGINAL PROJECT AND ONE GRANT WAS FUNDED. LEADERSHIP GRANTS: LEADERSHIP GRANTS PROVIDE SUPPORT FOR HYPOTHESIS-DRIVEN RESEARCH PROJECTS CONDUCTED BY THE DISTINGUISHED BREAST CANCER RESEARCHERS AND CLINICIANS WHO SERVE AS KOMEN'S SCIENTIFIC ADVISORS AND SEEK TO DISCOVER AND DELIVER THE CURES FOR BREAST CANCER. OPPORTUNITY GRANTS / STRATEGIC PARTNERSHIP AND PROGRAM GRANTS (OG/SPP): OG AND SPP GRANTS SUPPORT SPECIAL RESEARCH PROJECTS, PROGRAMS, AND COLLABORATIONS THAT LEVERAGE RESEARCH AND COMMUNITY RESOURCES TO FACILITATE THE DEVELOPMENT OF THE INFRASTRUCTURE, TOOLS, AND OTHER MEANS TO ACCELERATE THE TRANSLATION OF SCIENTIFIC DISCOVERIES FROM BENCH TO BEDSIDE TO CURBSIDE. FUNDING FROM ORGANIZATIONS LIKE KOMEN AND ITS SUPPORTERS HAS PROVEN CRITICAL FOR ALL THESE ACTIVITIES, ESPECIALLY AT A TIME OF DIMINISHING FEDERAL FUNDING FOR CANCER RESEARCH AND FOR CLINICAL TRIALS. KOMEN'S RESEARCH INVESTMENT THROUGH THESE GRANT MECHANISMS SUPPORTS PROJECTS THAT AIM TO, AMONG OTHER THINGS: (A) DEVELOP TARGETED THERAPIES;(B) OVERCOME AGGRESSIVE TYPES OF BREAST CANCER AND METASTASIS; (C) OVERCOME TREATMENT RESISTANCE; AND (D) UNDERSTAND AND ADDRESS DISPARITIES IN OUTCOMES.
EXAMPLES OF RESEARCH GRANTS AWARDED IN FY18 INCLUDE:A) TARGETED THERAPIES FOR TRIPLE-NEGATIVE BREAST CANCER: DR. SOHRAB SHAH FROM MEMORIAL SLOAN-KETTERING CANCER CENTER WAS AWARDED A LEADERSHIP GRANT TO COMBINE AND ANALYZE GENOMIC AND CLINICAL DATA FROM APPROXIMATELY 300 PATIENTS WITH TRIPLE NEGATIVE BREAST CANCER (TNBC) TO STUDY HOW MUTATIONS IN THE DNA OF TNBC CELLS CAN BE USED TO DESIGN BETTER TREATMENT APPROACHES. USING STATE-OF-THE-ART DNA SEQUENCING TECHNOLOGIES, DR. SHAH WILL MEASURE THE DNA OF INDIVIDUAL CANCER CELLS TO CREATE AN ULTRA-DETAILED PICTURE OF HOW TNBC CHANGES OVER TIME. THESE DETAILED VIEWS WILL REVEAL PREVIOUSLY UNSEEN PATTERNS OF DNA MUTATIONS IN TNBC, WHICH WILL BE USED TO STRATIFY PATIENTS INTO BIOLOGICALLY DISTINCT SUBGROUPS WITH DIFFERENT SENSITIVITIES TO CHEMOTHERAPY. THE DATA GENERATED FROM HIS PROJECT WILL BE USED TO HELP STRATIFY PATIENTS ACCORDING TO TREATMENT RESPONSE AND OUTCOMES, POTENTIALLY DIRECTING PATIENTS TO MORE TARGETED THERAPIES, WHICH ARE CURRENTLY LACKING FOR TNBC. B) OVERCOME AGGRESSIVE TYPES OF BREAST CANCER AND METASTASIS: DR. XIA LIU FROM NORTHWESTERN UNIVERSITY'S FEINBERG SCHOOL OF MEDICINE WAS AWARDED A CCR GRANT TO TEST WHETHER TWO NATURAL COMPOUNDS - HYPERFORIN AND BOSWELLIA - CAN BE USED ALONE OR IN COMBINATION WITH ANOTHER IMMUNOTHERAPY, A CHECKPOINT INHIBITOR CALLED ANTI PD-1 ANTIBODY, TO PREVENT THE ABILITY OF NEUTROPHILS TO PROMOTE METASTASIS. HYPERFORIN IS A PLANT-DERIVED ANTIBIOTIC FROM ST. JOHN'S WORT AND BOSWELLIA IS A PLANT THAT PRODUCES INDIAN FRANKINCENSE. DR. LIU WILL ALSO CONDUCT STUDIES TO UNCOVER HOW NEUTROPHILS INTERACT WITH TUMOR CELLS IN THE BLOOD TO PROMOTE METASTASIS. SHE WILL IDENTIFY THE MOLECULES THAT FACILITATE THIS INTERACTION AND DETERMINE WHETHER THESE MOLECULES CAN SERVE AS BIOMARKERS TO PREDICT METASTASIS IN PATIENTS WITH TRIPLE NEGATIVE BREAST CANCER, HELPING TO GUIDE TREATMENT STRATEGIES. C) OVERCOME TREATMENT RESISTANCE: DR. SVASTI HARICHARAN AT BAYLOR COLLEGE OF MEDICINE WAS AWARDED A CCR GRANT TO STUDY ENDOCRINE THERAPY RESISTANCE IN ER+ BREAST CANCER. PATIENTS WITH ESTROGEN RECEPTOR-POSITIVE (ER+) BREAST CANCER ARE TREATED WITH ENDOCRINE THERAPY, BUT ABOUT 1/3 OF ER+ PATIENTS DO NOT RESPOND TO THIS TREATMENT AND EVENTUALLY DIE OF THE DISEASE. DR. HARICHARAN HAS DISCOVERED THAT TUMORS WITH DEFECTS IN THEIR ABILITY TO REPAIR MISMATCHES IN DNA ARE RESISTANT TO ENDOCRINE THERAPIES, AND UP TO 30% OF ENDOCRINE TREATMENT RESISTANT TUMORS SHOW THIS DEFECT. DR. HARICHARAN WILL MOVE THIS DISCOVERY INTO THE CLINIC BY 1) DEVELOPING A SIMPLE DIAGNOSTIC TEST SO THAT CLINICIANS CAN IDENTIFY TUMORS WITH DEFECTIVE MISMATCH REPAIR AND 2) IDENTIFYING EXISTING FDA-APPROVED DRUGS THAT CAN TREAT THESE TUMORS MORE EFFECTIVELY THAN ENDOCRINE TREATMENT. THIS STUDY WILL HELP IDENTIFY WOMEN LIKELY TO DEVELOP DRUG RESISTANCE EARLY IN THE TIMELINE OF THEIR CANCER TREATMENT, PROVIDING DOCTORS A CRUCIAL OPPORTUNITY TO PERSONALIZE THERAPY TO EACH PATIENT. D) UNDERSTAND AND ADDRESS DISPARITIES IN OUTCOMES: RACHEL FREEDMAN, M.D., M.P.H., OF DANA-FARBER CANCER INSTITUTE WILL INVESTIGATE WAYS TO IMPROVE SURVIVAL FOR BREAST CANCER PATIENTS THAT ARE 70 YEARS OF AGE OR OLDER. OLDER PATIENTS OFTEN FACE WORSE OUTCOMES WHEN COMPARED TO THEIR YOUNGER COUNTERPARTS. THE GOAL OF THIS STUDY IS TO IDENTIFY TAILORED TREATMENT METHODS THAT WILL IMPROVE SURVIVAL FOR THIS POPULATION OF PATIENTS. KOMEN SCHOLAR JULIE PALMER, SC.D., OF BOSTON UNIVERSITY WILL DEVELOP A RISK PREDICTION TOOL THAT WILL CONSIDER THE DIFFERENT RISK FACTORS FOR ER+ AND ER- BREAST CANCER, ALONG WITH THE DIFFERING AGE INCIDENCE PATTERNS IN AFRICAN AMERICAN WOMEN. THIS TOOL WILL HELP IDENTIFY AFRICAN AMERICAN WOMEN WHO WOULD BENEFIT FROM EARLIER AND MORE FREQUENT SCREENING OR ALTERNATIVE MODES OF SCREENING. EDUCATION AND PATIENT SUPPORT: KOMEN IS A TRUSTED SOURCE OF BREAST CANCER INFORMATION FOR PEOPLE ALL OVER THE WORLD AND IS INSTRUMENTAL IN CONNECTING PEOPLE WITH THE RESOURCES THEY NEED IN THEIR FIGHT AGAINST BREAST CANCER. OUR WEBSITE, KOMEN.ORG, PROVIDES CURRENT, SAFE, ACCURATE, COMPREHENSIVE, AND UNBIASED INFORMATION ABOUT BREAST CANCER, BASED ON SCIENTIFIC EVIDENCE. CONTENT IS OFFERED IN A VARIETY OF FORMATS INCLUDING INTERACTIVE VIDEO USING ANIMATION AND VOICEOVER IN ENGLISH AND SPANISH, ILLUSTRATIONS, CHARTS, GRAPHS, AND SHORT VIDEOS TO MEET THE LEARNING PREFERENCES AND NEEDS OF OUR WEB VISITORS. THE "ABOUT BREAST CANCER" SECTION OF KOMEN'S WEBSITE, CO-DEVELOPED WITH HARVARD MEDICAL SCHOOL FACULTY AND DANA-FARBER/BRIGHAM AND WOMEN'S CANCER CENTER STAFF, RECEIVED MORE THAN 5.6 MILLION PAGE VIEWS DURING FY18. KOMEN ALSO PROVIDES EVIDENCE-BASED, EASY-TO-READ EDUCATIONAL MATERIALS IN DOWNLOADABLE FORMATS ON KOMEN.ORG. EXAMPLES OF KOMEN EDUCATIONAL MATERIALS INCLUDE: A) BREAST SELF-AWARENESS MESSAGE CARDS IN MORE THAN 40 LANGUAGES, B) BREAST CANCER SPECIFIC BROCHURES AND FACTSHEETS, C) BOOKLETS WITH SUPPORT INFORMATION FOR SURVIVORS AND CO-SURVIVORS, AND D) TOOLKITS FOR BREAST CANCER OUTREACH AND EDUCATION FOR HISPANIC/LATINO IN ENGLISH AND SPANISH AND FOR BLACK AND AFRICAN-AMERICAN COMMUNITIES. THE SUSAN G. KOMEN "1-877 GO KOMEN" (1-877-465-6636) BREAST CARE HELPLINE OFFERS BREAST CANCER EDUCATION, PSYCHOSOCIAL SUPPORT, AND INFORMATION ABOUT COMMUNITY RESOURCES FOR PATIENTS, FAMILIES, AND FRIENDS. IN FY18, KOMEN ADDED A CLINICAL TRIAL INFORMATION HELPLINE TO PROVIDE INFORMATION, RESOURCES, COACHING AND SUPPORT RELATED TO BREAST CANCER CLINICAL TRIALS. THE HELPLINE OPERATES FROM 9 A.M. - 10 P.M. E.T. THE SERVICE IS OFFERED IN ENGLISH, SPANISH, AND TAGALOG. DURING FY18, THE KOMEN BREAST CANCER HELPLINE RESPONDED TO MORE THAN 13,000 CALLS AND EMAILS. IN ADDITION, IN FY18 KOMEN SUPPORTED TWO NONPROFIT ADVOCACY ORGANIZATIONS TO PRESENT PATIENT-FOCUSED, EDUCATIONAL CONFERENCES DEDICATED TO THE CRITICAL ISSUES FACING BREAST CANCER PATIENTS AND THEIR FAMILIES. KOMEN FUNDS THE LIVING BEYOND BREAST CANCER'S (LBBC) CONFERENCE FOR WOMEN LIVING WITH METASTATIC BREAST CANCER IN THE WASHINGTON, D.C. REGION. THE CONFERENCE BRINGS PEOPLE WITH METASTATIC BREAST CANCER, CAREGIVERS, HEALTHCARE PROFESSIONALS, HEALTHCARE ORGANIZATIONS, SUPPORT ORGANIZATIONS AND OTHERS, WHO PARTICIPATE IN THE CARE OF PATIENTS WITH METASTATIC BREAST CANCER, TO DISCUSS SCIENTIFIC BREAKTHROUGHS, ONGOING CLINICAL TRIALS, QUALITY OF LIFE, AND INTEGRATIVE MEDICINE. THE CONFERENCE IS DESIGNED TO FILL THE NEEDS OF THE METASTATIC BREAST CANCER COMMUNITY AND SEEKS TO STRENGTHEN METASTATIC BREAST CANCER VOICES IN THE NATIONAL CAPITAL REGION BY CREATING OPPORTUNITIES FOR LEARNING, ENGAGEMENT AND ACTION. BREAST CANCER IS THE MOST COMMON CANCER IN WOMEN, WORLDWIDE, AND THE NUMBER OF CASES IS INCREASING IN NEARLY EVERY COUNTRY. THE NUMBER OF NEW BREAST CANCER CASES HAS MORE THAN DOUBLED AROUND THE WORLD IN THE LAST THREE DECADES, WITH HIGHEST INCREASES OBSERVED IN LOW- AND MIDDLE-INCOME COUNTRIES. BREAST CANCER IS ALSO THE LEADING CAUSE OF CANCER DEATH IN THESE COUNTRIES, WITH OVER 500,000 DEATHS IN 2012. THESE TRENDS ARE CONCERNING, WHICH IS WHY KOMEN WORKS TIRELESSLY TO PROVIDE SUPPORT TO BREAST HEALTH PROGRAMS WORLDWIDE. IT TAKES COLLABORATION AND STRONG PARTNERSHIPS TO MAKE A GLOBAL IMPACT. KOMEN STRIVES TO SERVE AS A "BRIDGE" - COLLABORATING WITH INTERNATIONAL NONPROFITS, CORPORATIONS, AND MINISTRIES OF HEALTH TO BRING TOGETHER PEOPLE AND ORGANIZATIONS TO DEVELOP PROGRAMS THAT ARE TAILORED TO THE SPECIFIC NEEDS OF THE COMMUNITY AND SENSITIVE TO CULTURAL DIFFERENCES. IN FY18, KOMEN'S GLOBAL PROGRAM AWARDED TEN GRANTS TO SUPPORT EDUCATION PROGRAMMING FOR PATIENTS AND FOR HEALTH PROFESSIONALS AND TO REDUCE BARRIERS TO BREAST CANCER CARE IN CHINA, COLOMBIA, MEXICO, PANAMA, AND ZAMBIA. IN ZAMBIA, SUSAN G. KOMEN PARTNERED WITH CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA (CIDRZ) TO CONVENE THE CANCER PREVENTION ALLIANCE OF ZAMBIA (CAPRAZ). THIS COUNTRY-WIDE ALLIANCE OF CANCER ADVOCACY GROUPS WILL WORK TO INTENSIFY BREAST AND CERVICAL CANCER EDUCATION CAMPAIGNS IN COMMUNITIES TO DISPEL MYTHS AND MISCONCEPTIONS; ENSURE THE BREAST AND CERVICAL CANCER HEALTH PROMOTION MESSAGES ARE EVIDENCE-BASED AND CONTEXTUALLY RELEVANT; AND COORDINATE AND PROVIDE TECHNICAL SUPPORT FOR EDUCATION ACTIVITIES OF MEMBER GROUPS.
PUBLIC POLICY AND ADVOCACYSUSAN G. KOMEN IS THE VOICE FOR THE MORE THAN 3.5 MILLION BREAST CANCER SURVIVORS AND THOSE WHO LOVE THEM. KOMEN WORKS TO ENSURE THAT THE FIGHT AGAINST BREAST CANCER IS A PRIORITY AMONG POLICYMAKERS IN WASHINGTON, D.C., AND EVERY STATE CAPITOL ACROSS THE COUNTRY. EVERY TWO YEARS, THROUGH A TRANSPARENT, BROAD-BASED AND INTENSIVE VETTING AND SELECTION PROCESS, KOMEN WORKS TO IDENTIFY THE POLICY ISSUES WITH THE GREATEST POTENTIAL MISSION IMPACT. THIS PROCESS INCLUDES COLLECTING FEEDBACK FROM KOMEN HEADQUARTERS' LEADERSHIP, POLICY STAFF, AND SUBJECT MATTER EXPERTS; KOMEN AFFILIATES FROM ACROSS THE COUNTRY; ADVISORY GROUPS INCLUDING ADVOCATES IN SCIENCE (AIS) AND KOMEN SCHOLARS; AND OTHER STAKEHOLDERS WITH A VESTED INTEREST IN BREAST CANCER-RELATED ISSUES. THE SELECTED ISSUES ARE THE BASIS FOR KOMEN'S STATE AND FEDERAL ADVOCACY. KOMEN'S 2017-2018 ADVOCACY PRIORITIES INCLUDED: SUPPORTING EXPANDED FEDERAL FUNDING FOR BREAST CANCER RESEARCH AT THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE DEPARTMENT OF DEFENSE (DOD); SUPPORTING STATE AND FEDERAL FUNDING FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION'S (CDC) NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM (NBCCEDP); ADVOCATING FOR STATE AND FEDERAL POLICIES TO IMPROVE INSURANCE COVERAGE OF BREAST CANCER TREATMENTS, INCLUDING THOSE THAT WOULD REQUIRE ORAL PARITY, PRECLUDE SPECIALTY TIERS AND PREVENT STEP THERAPY PROTOCOLS; ADVOCATING FOR STATE AND FEDERAL POLICIES TO REDUCE OR ELIMINATE OUT-OF-POCKET COSTS FOR MEDICALLY NECESSARY DIAGNOSTIC MAMMOGRAPHY; AND EVALUATING STATE AND FEDERAL POLICIES TO INCREASE PUBLIC ACCESS TO INFORMATION ABOUT AND PARTICIPATION IN CLINICAL TRIALS FOR ALL PATIENT POPULATIONS. IN ADDITION TO THE STATE AND FEDERAL WORK ON OUR 2017-2018 ADVOCACY PRIORITIES, KOMEN CONTINUED OUR EFFORTS TO ENSURE EVERY BREAST CANCER PATIENT AND SURVIVOR HAS ACCESS TO AFFORDABLE, QUALITY HEALTH INSURANCE AND CARE. KOMEN ALSO ENGAGED ON ISSUES RELATED TO BREAST DENSITY, COMPASSIONATE USE, GENETIC TESTING, HEALTH DISPARITIES, LYMPHEDEMA, METASTATIC BREAST CANCER, PALLIATIVE CARE AND SURVIVORSHIP. KOMEN DEVELOPED AND IMPLEMENTED ADVOCACY CAMPAIGNS TO ENCOURAGE LAWMAKERS AND AGENCY OFFICIALS TO SUPPORT AND IMPLEMENT PROGRAMS THAT WOULD ADVANCE OUR PRIORITY ISSUES AND ADDITIONAL POLICY AREAS TO ACHIEVE KOMEN'S BOLD GOAL. KOMEN CONTINUED TO RECRUIT AND ENGAGE ADVOCATES TO FURTHER STRENGTHEN ITS GRASSROOTS ADVOCACY NETWORK. SCREENING AND PATIENT NAVIGATION GETTING REGULAR SCREENING TESTS, ALONG WITH EFFECTIVE AND QUALITY TREATMENT IF DIAGNOSED, LOWERS THE RISK OF DYING FROM BREAST CANCER. SCREENING TESTS CAN FIND BREAST CANCER EARLY, WHEN CHANCES FOR SURVIVAL ARE HIGHEST. PATIENT NAVIGATION IS A PROCESS BY WHICH AN INDIVIDUAL - A PATIENT NAVIGATOR - GUIDES PATIENTS THROUGH AND AROUND BARRIERS IN THE COMPLEX CANCER CARE SYSTEM. EVIDENCE SHOWS NAVIGATION IMPROVES ADHERENCE TO SCREENING RECOMMENDATIONS, AND THUS IMPROVES OVERALL OUTCOMES. KOMEN SUPPORTS FREE AND LOW-COST SCREENING PROGRAMS IN UNDERSERVED COMMUNITIES THAT HELP NAVIGATE PEOPLE TO QUALITY CARE, AND/OR PROVIDE COVERAGE FOR SCREENING SERVICES TO PEOPLE WITHOUT HEALTH INSURANCE, OR THOSE WITH HIGH CO-PAYS AND DEDUCTIBLES THAT MAKE SCREENING TOO COSTLY. IN FY18, KOMEN AWARDED ONE SCREENING COMMUNITY GRANT TO THE AMERICAN ASSOCIATION ON HEALTH AND DISABILITY. THE PROJECT FOCUSES ON WOMEN WITH DISABILITIES IN WASHINGTON D.C., PARTICULARLY BLACK AND AFRICAN-AMERICAN WOMEN, WITH THE ULTIMATE GOAL OF INCREASING BREAST CANCER CARE UTILIZATION THROUGH DECREASING BARRIERS TO ACCESS CARE, LEADING TO REDUCED MORTALITY. THROUGH ITS GLOBAL PROGRAM, KOMEN AWARDED TEN GRANTS TO COMMUNITY ORGANIZATIONS IN SUPPORT OF SCREENING AND PATIENT NAVIGATION PROGRAMS IN MEXICO, PANAMA, CHINA, COLUMBIA, AND ZAMBIA. TREATMENT AND PATIENT NAVIGATION BARRIERS TO QUALITY CARE ARE OFTEN ASSOCIATED WITH POOR BREAST CANCER OUTCOMES AND RESULTANT CANCER DISPARITIES AMONG SPECIFIC POPULATION GROUPS. ACCORDING TO QUALITATIVE DATA COLLECTED FROM ACROSS KOMEN'S AFFILIATE NETWORK, THE MOST COMMON BARRIERS TO QUALITY CARE IN THE UNITED STATES INCLUDE: (1) AVAILABILITY OF LOCAL SERVICES; (2) BREAST CANCER EDUCATION; (3) CULTURAL/LANGUAGE; (4) FEAR; (5) FINANCIAL; (6) INSURANCE; (7) TRANSPORTATION. PATIENT NAVIGATION IS A PROCESS BY WHICH AN INDIVIDUAL - A PATIENT NAVIGATOR - GUIDES PATIENTS THROUGH AND AROUND BARRIERS IN THE COMPLEX CANCER CARE SYSTEM TO ENSURE TIMELY DIAGNOSIS AND TREATMENT. EVIDENCE SHOWS PATIENT NAVIGATION IMPROVES ADHERENCE TO TREATMENT RECOMMENDATIONS, RESULTING IN IMPROVED OUTCOMES. IN FY18, KOMEN FUNDED THREE NONPROFIT ORGANIZATIONS IN SUPPORT OF PROGRAMS TO REDUCE STRUCTURAL, PERSONAL, SOCIOCULTURAL, AND FINANCIAL BARRIERS TO CARE, AND PROVIDE PATIENT NAVIGATION SERVICES FOR UNDERSERVED COMMUNITIES IN THE WASHINGTON, D.C. METRO AREA, SPECIFICALLY WARDS 2, 5, 7, AND 8, AND ALEXANDRIA CITY, VA. THROUGH ITS GLOBAL PROGRAM IN FY18, KOMEN AWARDED TEN GRANTS TO COMMUNITY ORGANIZATIONS IN SUPPORT OF TREATMENT AND PATIENT NAVIGATION PROGRAMS AND TO REDUCE BARRIERS TO BREAST CANCER CARE IN CHINA, COLOMBIA, MEXICO, PANAMA, AND ZAMBIA. FOR EXAMPLE, KOMEN SUPPORTED CASITA DE MAUSI TO PROVIDE LODGING, TRANSPORTATION, AND MEALS FOR BREAST CANCER PATIENTS FROM RURAL COMMUNITIES IN PANAMA, FACILITATING THEIR ACCESS TO BREAST CANCER SERVICES. KOMEN ALSO SUPPORTED ALIANZA MEXICANA POR EL CNCER IN MEXICO TO IMPROVE THE CURRENT OUTLOOK OF BREAST CANCER IN MEXICO THROUGH THE EARLY DETECTION, DIAGNOSIS, AND TREATMENT OF BREAST CANCER; IMPROVING CLINICAL CARE OF PATIENTS; ENCOURAGING MULTIDISCIPLINARY RESEARCH OF BREAST CANCER IN MEXICO; EXPANDING THE EDUCATION OF THE PUBLIC, PATIENTS, AND HEALTH PROFESSIONALS; AND GUARANTEEING THE REPLICABILITY OF THE PROGRAMS WE FOSTER. KOMEN'S TREATMENT ASSISTANCE PROGRAM, ADMINISTERED BY CANCERCARE, AIMS TO HELP WOMEN AND MEN IN BREAST CANCER TREATMENT WHO ARE FACING FINANCIAL CHALLENGES BY PROVIDING LIMITED FINANCIAL ASSISTANCE, EDUCATION, AND SUPPORT SERVICES. FINANCIAL ASSISTANCE IS GRANTED TO UNDERSERVED, UNDERINSURED OR UNINSURED WOMEN AND MEN ACROSS THE COUNTRY UNDERGOING BREAST CANCER TREATMENT WHO MEET PRE-DETERMINED ELIGIBILITY CRITERIA. THIS PROGRAM PROVIDES FINANCIAL ASSISTANCE FOR TREATMENT-RELATED COSTS, INCLUDING TRANSPORTATION TO AND FROM TREATMENT, CHILD/ELDER CARE, HOME CARE, ORAL PAIN/ANTI-NAUSEA MEDICATIONS, ORAL CHEMOTHERAPY/HORMONE THERAPY, LYMPHEDEMA CARE/SUPPLIES, PALLIATIVE CARE, AND DURABLE MEDICAL EQUIPMENT. WE SERVED MORE THAN 3200 PEOPLE THROUGH THIS PROGRAM IN FY18. EXECUTIVE COMMITTEE FORM 990, PART VI, LINE 1A THE ORGANIZATION'S BYLAWS PROVIDE FOR AN EXECUTIVE COMMITTEE COMPRISED OF A MINIMUM OF FIVE MEMBERS INCLUDING THE BOARD CHAIR, THE PRESIDENT AND CHIEF EXECUTIVE OFFICER, AND ADDITIONAL BOARD MEMBERS, AS RECOMMENDED BY THE GOVERNANCE COMMITTEE AND APPOINTED BY THE BOARD OF DIRECTORS. MEMBERS OF THE EXECUTIVE COMMITTEE MUST EITHER BE DIRECTORS OF THE ORGANIZATION OR THE PRESIDENT AND CHIEF EXECUTIVE OFFICER. THE BYLAWS PROVIDE THE EXECUTIVE COMMITTEE WITH THE AUTHORITY TO: (A) APPOINT MEMBERS TO NON-STANDING COMMITTEES OF THE ORGANIZATION, AND NAME CHAIRS OF SUCH COMMITTEES; (B) AUTHORIZE UNBUDGETED DISBURSEMENTS BY THE ORGANIZATION IN ACCORDANCE WITH THE SPECIFIC EXPENDITURE AUTHORITY PRESCRIBED BY THE BOARD OF DIRECTORS; (C) EMPLOY AGENTS; AND (D) CARRY INTO EXECUTION SUCH OTHER MEASURES AS IT DETERMINES WILL PROMOTE THE PURPOSE OF THE ORGANIZATION. THE COMMITTEE ALSO MAY EXERCISE, WHEN THE BOARD IS NOT IN SESSION, ALL OF THE AUTHORITY OF THE BOARD IN THE MANAGEMENT OF THE BUSINESS AND AFFAIRS OF THE ORGANIZATION WITH CERTAIN EXCEPTIONS SUCH AS REPEALING ANY BOARD RESOLUTIONS, AMENDING THE ORGANIZATION'S ARTICLES OR BYLAWS, OR MERGING OR DISSOLVING THE ORGANIZATION. THIS DELEGATION DOES NOT RELIEVE THE BOARD OF ANY OF ITS RESPONSIBILITIES IMPOSED BY LAW, AND THE COMMITTEE ENDEAVORS TO LIMIT ITS EXERCISE OF AUTHORITY TO TIME SENSITIVE ISSUES. DESCRIBE THE PROCESS USED BY MANAGEMENT &/OR GOVERNING BODY TO REVIEW 990 FORM 990, PART VI, LINE 11B MANAGEMENT PREPARES THE MATERIALS FOR THE FORM 990, WITH THE ASSISTANCE OF AND REVIEW BY EXTERNAL ACCOUNTANTS. SENIOR LEVEL MANAGEMENT REVIEW AND COMMENT ON THE FINAL DRAFT OF THE FORM 990 FOR SUBSEQUENT PRESENTATION TO THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS. THE AUDIT COMMITTEE REVIEWS, MAKES RECOMMENDATIONS, AND APPROVES THE FORM 990 FOR PRESENTATION TO THE BOARD OF DIRECTORS. THEREAFTER, THE BOARD OF DIRECTORS REVIEWS AND APPROVES THE FORM 990 PRIOR TO FILING.
DESCRIPTION OF PROCESS TO MONITOR TRANSACTIONS FOR CONFLICTS OFINTEREST FORM 990, PART VI, LINE 12C KOMEN PRODUCES AN ANNUAL SURVEY REQUIRING ALL EMPLOYEES, BOARD MEMBERS, COMMITTEE MEMBERS, AND ADVISORY BOARD MEMBERS TO DISCLOSE ANY POTENTIAL OR ACTUAL CONFLICTS OF INTEREST THEY MAY HAVE. ANY REPORTED POTENTIAL OR ACTUAL CONFLICTS ARE THEN REVIEWED BY SENIOR MANAGEMENT AND THE AUDIT COMMITTEE, WHEREUPON APPROPRIATE MEASURES ARE TAKEN. ALL EMPLOYEES, BOARD MEMBERS, COMMITTEE MEMBERS AND ADVISORY BOARD MEMBERS ARE REQUIRED TO UPDATE THEIR RESPECTIVE CONFLICT OF INTEREST DISCLOSURES AS NECESSARY DURING THE YEAR.
OFFICES & POSITION FOR WHICH PROCESS WAS USED, & YEAR PROCESS WASBEGUN FORM 990, PART VI, LINES 15A AND 15B THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS ASSISTS THE BOARD IN OVERSEEING COMPENSATION POLICIES AND BEST PRACTICES. RESPONSIBILITIES INCLUDE OVERSIGHT OF THE COMPENSATION OF THE CHIEF EXECUTIVE OFFICER; THE RANGE OF COMPENSATION LEVELS FOR THE ORGANIZATION'S OTHER OFFICERS, DISQUALIFIED PERSONS, AND OTHER KEY EMPLOYEES; GRANTING THE CHIEF EXECUTIVE OFFICER WITH THE AUTHORITY TO DETERMINE COMPENSATION LEVELS WITHIN AN APPROVED RANGE; AND ANY INCENTIVE/BONUS COMPENSATION PROGRAMS, IF APPROVED. THE CURRENT POLICY WAS ADOPTED IN 2010. A FORMAL COMPENSATION POLICY GOVERNS PAY PRACTICES. PERIODICALLY, ALL POSITIONS IN THE ORGANIZATION ARE REVIEWED AGAINST EXTERNAL MARKET DATA BY ENGAGING INDEPENDENT EXPERTS OR ACQUIRING UPDATED MARKET DATA TO CONDUCT THE BENCHMARKING PROCESS. COMPENSATION IS THEN BASED UPON COMPARABLE MARKET RATES OF PAY WITH CONSIDERATION FOR INTERNAL EQUITY AND THE FINANCIAL POSITION OF THE ORGANIZATION. BENCHMARKING WAS CONDUCTED FOR THE CHIEF EXECUTIVE OFFICER AND ALL EXECUTIVE TEAM MEMBERS' COMPENSATION TO EXTERNAL MARKET DATA IN 2017, TO ENSURE MARKET ALIGNMENT. KOMEN PROVIDES SALARY INCREASES, PROMOTIONS AND OTHER FORMS OF COMPENSATION WITHOUT REGARD TO RACE, COLOR, RELIGION, GENDER, NATIONAL ORIGIN, DISABILITY, VETERAN STATUS OR SEXUAL ORIENTATION.
AVAIL OF GOV DOCS, CONFLICT OF INTEREST POLICY, & FIN STMTS TOGEN PUBLIC FORM 990, PART VI, LINE 19 KOMEN'S FINANCIAL STATEMENTS AND THE FORM 990 ARE PUBLICLY AVAILABLE ON OUR WEBSITE. THE CERTIFICATE OF FORMATION IS AVAILABLE FROM THE TEXAS SECRETARY OF STATE AND OTHER GOVERNING DOCUMENTS ARE MADE AVAILABLE AS REQUIRED BY STATE LAW. FORM 1023 AND THE CONFLICT OF INTEREST POLICY ARE NOT PUBLISHED ONLINE BUT ARE AVAILABLE TO THE PUBLIC UPON REQUEST.
ADDITNL DETAIL ON EVENT PRODUCTION EXPENSES INCLUDED ON OTHER EXPFORM 990, PART IX, LINE 24 KOMEN PAYS 50% OF THE COST OF ALL T-SHIRTS FOR THE 125 SUSAN G. KOMEN RACE FOR THE CURE EVENTS CONDUCTED BY THE KOMEN AFFILIATES DURING THE FISCAL YEAR.
OTHER CHANGES IN NET ASSETS OR FUND BALANCESFORM 990, PART XI, LINE 9 RESCINDED GRANTS $2,093,947 AFFILIATE RACE SERIES DIRECT BENEFIT $ 939,930 ------------ TOTAL $3,033,877 ============